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MODELLING PROTEIN BACKBONE LOOP USING
THE MONTE CARLO METHOD
by Juan Fernandez Carmona
Novel methods that perform local moves such as the gaussian bias or Con-
certed Rotation with Angles, increase the exploration of the conformational
phase space. These methods have been applied successfully to small systems,
and have proved to be more eﬃcient than the classical Monte Carlo method.
The main aim of my work was to study and include backbone moves
for proteins, such as the Concerted Rotation with Angle (CRA) and the
gaussian bias in the ProtoMS package. The CRA was then applied to several
systems of biological interest to compute relative binding free energies and
conformational changes to obtain insights into the binding mode and system
ﬂexibility.
The CRA algorithm has been used to sample biological systems such
as lysozyme L99A mutant, Bcr-Abl kinases and PDE5 phosphodiesterase
and led to increased sampling of the backbone and more precise free energy
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Introduction
1.1 Aims
The aim of this work is to implement novel methods to increase the sampling
of the backbone of proteins using stochastic simulations. For these methods
to be become widely used, they must be able to enhance the sampling of
the protein backbone, to increase accuracy of relative binding free energy
computations where the sampling is a limiting factor, and to perform reliably
under the constraints of the pharmaceutical industry. The methods should
be fast and require as little user intervention as possible.
1.2 Drug design
From a chemical point of view, the design of active substrates for a given
protein is a diﬃcult and expensive process. For a drug to be eﬃcient and
have little or no side eﬀects it has to be very selective to its target. To test
the eﬃciency and selectivity of a molecule towards a given biological target,
one option is to do expensive experimental screening via automatic testing.
Such testing makes the production of a drug very cost ineﬀective.
Long gone are the day of experimental automatic testing (although some
virtual screening for lead optimisation still exists). Nowadays, our under-CHAPTER 1. INTRODUCTION 2
standing of the mechanisms involved in the binding process is widely used
to lead to the design of new drugs. The use of experimental crystal or NMR
structures and modelling methods allows the drug design process to be more
eﬃcient. This process is called rational drug design1. Rational drug design
aims to gather knowledge of the structure of the protein and existing lig-
and(s), and to study the interaction between these to lead to the design of
new compounds. Having eﬃcient and cheap computational methods should
make the trial and error test obsolete and decrease the cost of bringing a new
drug to the market.
Since the 1990s, computational chemistry has emerged as a technique of
choice to investigate both protein folding and protein behaviour in vacuum
or solvent2. Development of methods such as molecular modelling, scoring
functions or free energy perturbation and a rise in hardware developments∗
have resulted in a major breakthrough in rational drug design4–6.
The use of molecular modelling to investigate protein behaviour in sol-
vent has become more and more reliable and faster as computing costs have
been reduced. Nowadays, methods such as free energy perturbation can be
applied to more systems to investigate protein ﬂexibility or ligand selectivity.
There is still some space for interesting challenges in the ﬁeld of computa-
tional chemistry such as folding of proteins into their native structure or
sampling the activation pathway leading to domain motions, since very little
information is available from an experimental point of view.
Insights into the conformational changes related to the binding mecha-
nism, would provide the knowledge to design selective compounds and reduce
the cost of new drugs.
∗Moore stated in 1965 that the number of processor would double every year3. CPU
speed in 1990 was 25 MHz with a 30 MHz CPU project from Intel, whereas now most of
the desktop have now 3.2 GHz dual or even quad core processors inside. The memory and
storage capabilities of computers has increased by a factor of thousand (having several
GBytes of RAM is nowadays common even on the cheapest desktop machines).CHAPTER 1. INTRODUCTION 3
1.3 Rigorous methods for rational drug de-
sign
The primary techniques used to calculate the physical properties of models
of proteins are molecular dynamics simulations (MD) and Monte Carlo (MC)
methods which have become more accurate in recent years. Considering the
wealth of other related methods to enhance sampling of protein that have
been recently employed (including minimisation techniques7, conformational
space annealing8,9, multi-canonical simulation10,11, and more recently replica
exchange methods12, digital ﬁltering13,14, and ensemble dynamics15,16) the
use of molecular modelling is now able to provide most of the information on
a chosen system.
However, in spite of hardware and method developments, studying com-
plete folding, or sampling large-scale activation pathways using traditional
molecular mechanics methods such as molecular dynamics or Monte Carlo
has, until recently, been beyond the computational possibilities for any but
the smallest systems.
MD simulations use force ﬁelds and a time step to numerically inte-
grate Newton’s laws. They aim to explore the phase space by building up a
time/conformation relationship. The ability to use explicit solvation and to
obtain dynamic properties of a system is one of the advantages of MD. One
of the main weaknesses is that a system can become trapped in a local energy
minimum (in a computational accessible timescale), limiting exploration of
the potential energy surface and leading to convergence problems. So far,
average MD studies are no longer than approximately 100 ns, whereas most
of the conformational biological processes such as folding, occur in the range
of microsecond or millisecond.
MC simulations aim, on the other hand, to generate a trajectory through
phase space which samples from a statistical ensemble. The step n + 1 is
chosen by randomly moving one or several atoms or degrees of freedom (dof ).
The energy of the new conﬁguration has to satisfy the Metropolis criterion17
in order to be accepted as a new conﬁguration (see section 3.3). Through
a judicious choice of moves, this method allows some energy barriers to beCHAPTER 1. INTRODUCTION 4
stepped over. However, the random generation of a new protein backbone
conformation often leads to side chain clashes resulting in a high energy
state and a rejected move. This problem has been addressed using speciﬁc
methods and algorithms for the sampling of proteins by MC methods.
In theory, both MD and MC should lead to the same results, despite the
fact they work in diﬀerent ways. The time averaged properties (for MD), or
the ensemble average properties (for MC) should be identical for the same
system, provided the simulations are run for long enough. There are not
absolute rules to decide which method to use. Systems, models, force ﬁelds
and the properties to be measured lead to the choice of one method rather
than the other. In MD, it is very diﬃcult to explore all the potential energy
surface, particularly when two states with similar potential energy are sep-
arated with a high energy barrier. Such phase space sampling problems are
less likely to occur with the MC method, as ”jumps” over energy barriers are
possible.
1.4 Concluding remarks
Modelling methods are able to give insights of protein conformational changes
non accessible using experimental techniques. Such conformational changes
are however very diﬃcult to model using traditional molecular modelling.
MD methods can be trapped in local energy minima. MC methods are able
to jump over energy barriers, but sampling large backbone moves is diﬃcult.
For both MD and MC advanced sampling methods have been developed to
address these issues.
The next chapter will give brief information on a protein structure, how
do they fold and what are the mechanisms responsible for that. Then theory
beyond the MC and MD methods will be describe. The last part of the
background overview will be a review of the existing speciﬁc algorithms for
the Monte Carlo method with a focus on the methods used during my PhD.Chapter 2
Protein structure
A protein is a complex macromolecule, composed of polymeric amino-acid
chains18. The three-dimensional structure of a protein is the consequence of
several factors and interactions described below.
2.1 Amino-acids and protein structure
In biochemistry, amino acids refer to the general formula H2NCHRCOOH,
where R is an organic substituent (see ﬁgure 2.1). In the α-amino acids,
Figure 2.1: Representation of an amino-acid18. R represents the side chain
of the amino acid.CHAPTER 2. PROTEIN STRUCTURE 6
the amino and carboxylate groups are attached to the same carbon, which is
called the α carbon, the substituent R is referred to as the side chain. The
various α amino acids diﬀer in which side chain (R group) is attached to their
α carbon. They can vary in size from just a hydrogen atom in glycine through
a methyl group in alanine to a large heterocyclic group in tryptophan (see
table 2.1 for the list of common amino acids). In a protein, the amide bond
Amino Acid 3-Letter 1-Letter Polarity Acidity or basicity
Alanine Ala A non-polar neutral
Arginine Arg R polar basic (strongly)
Asparagine Asn N polar neutral
Aspartic acid Asp D polar acidic
Cysteine Cys C polar neutral
Glutamic acid Glu E polar acidic
Glutamine Gln Q polar neutral
Glycine Gly G non-polar neutral
Histidine His H polar basic (weakly)
Isoleucine Ile I non-polar neutral
Leucine Leu L non-polar neutral
Lysine Lys K polar basic
Methionine Met M non-polar neutral
Phenylalanine Phe F non-polar neutral
Proline Pro P non-polar neutral
Serine Ser S polar neutral
Threonine Thr T polar neutral
Tryptophan Trp W non-polar neutral
Tyrosine Tyr Y polar neutral
Valine Val V non-polar neutral
Table 2.1: Amino acid nomenclature
is referred as the peptide bond. In a peptide bond, the C, O, N, H atoms are
in the same plane (thus forming a dihedral angle of 180 degree, or 0 degree
for the proline 0).
Amino acids can be combined to form the structure of many diﬀerent
proteins in the same fashion letters can be combined to form many diﬀer-
ent words. This combination is known as the primary structure of the pro-CHAPTER 2. PROTEIN STRUCTURE 7
tein 2.2(a). Protein are not linear macro molecules and due to internal forces,
(a) Representation of primary struc-
ture of a protein.
(b) Representation of an α-helix
(red) and βsheet (yellow).
(c) Representation of tertiary struc-
ture.
(d) Representation of a quaternary
structure.
Figure 2.2: Representation of protein structures.19
they adopt folded conformations. These conformations are diﬀerent for each
protein, and referred as secondary 2.2(b) and tertiary 2.2(c) structures. The
secondary structure is partly the consequence of the H-bonding interactions
between the oxygen of the carboxyl group of one amino acid and the hy-
drogen of the amide functions of another. The principal folds for secondary
structure are the α-helix, and β-sheet. In the α-helix, the amino-acids roll in
an anticlockwise direction and the side chains are on the outside of the helix.
In the fully extended β strand, successive side chains point straight up, thenCHAPTER 2. PROTEIN STRUCTURE 8
straight down, then straight up, etc. In parallel β-sheet, sides chains point to-
ward the same direction, whereas in anti parallel β-sheet, side chains point in
opposite direction (see ﬁgure 2.1). However, other extended structures such
(a) Representation of a parallel β-sheet.
(b) Representation of an antiparrallel β-sheet.
Figure 2.3: Representation of antiparallel and parallel β-sheet.
as the polyproline helix and alpha sheet are rare in native state proteins but
are often hypothesised as important protein folding intermediates18. Other
types of helices exist such as 310-helix or the π-helix20–22. Tight turns and
lose, ﬂexible loops link the more ”regular” secondary structure elements. The
random coil is not a true secondary structure, but is the class that indicates
an absence of regular secondary structure. The overall 3D structure of the
polypeptide chain is referred to as the protein tertiary structure. The ter-
tiary structure of a protein describes the way the secondary structure folds
into a more compact conformation using a variety of turns and shapes (ﬁg-
ure 2.2(c)). Tertiary structure is stabilised by H-bonding, ionic eﬀects, nonCHAPTER 2. PROTEIN STRUCTURE 9
polar interactions, or sometimes by disulphide bridges. For some proteins
with an important number of residues, peculiar reorganisation can occur:
several motifs pack together to form compact, local, semi-independent units
called domains. A structural domain is an element of the protein’s overall
structure that is self-stabilising and often folds independently of the rest of
the protein chain. Each domain contains an individual hydrophobic core built
from secondary structure units connected by loop regions.
Many proteins are actually assemblies of more than one polypeptide chain,
which in the context of the larger assembly are known as protein subunits.
The quaternary protein structure involves the clustering of several subunits
into a ﬁnal speciﬁc shape(ﬁgure 2.2(d)). There are two major categories of
proteins with quaternary structure - ﬁbrous and globular.
2.2 Protein ﬂexibility
The understanding of protein 3D structure is one of the most important
keys in the synthesis of inhibitors and medical drugs (for more details on
protein structures see reference18). Proteins are not ﬁxed structures and due
to internal and external forces, their shape changes by contracting or relaxing
with time (often called protein breathing). The lock and key model (see
ﬁgure 2.4) for a protein-ligand interaction is now known to be incomplete
due to the protein dynamics23.
Being able to investigate structure-function relationships and obtain in-
sights of protein behaviour is a key of modern computational chemistry, and
could lead to major breakthrough in understanding binding processes. As a
protein breathes, internal degrees of freedom change, and binding features
evolve. Getting information on how these features change and how the lig-
and binding mode evolves can lead to better drug design and an increase in
the eﬃciency of a drug. There are several possible ﬂuctuations for proteins.
The simplest is side chain motion, where internal degrees of freedom along
the side chain move according to internal or external forces. For example,
a protein bound to diﬀerent ligand with diﬀerent rotamers to accommodate
the change of volume25.CHAPTER 2. PROTEIN STRUCTURE 10
Figure 2.4: Lock and key model for protein24.
Then backbone motions are involved. Such moves can be simple changes
in the Ramachadran angles26 or bond angles to make a section of the pro-
tein wriggle, or larger moves such as loop conformation changes and domain
motions.
Figure 2.5 shows the CDK-2 kinase in both active and inactive forms.
The key loop to the binding site (ﬂat in the picture) sees its conformation
changed during the activation process.
The presence of multiple domains in proteins gives rise to a great deal
of ﬂexibility and mobility27. Several domain motions can occur to change
the conformation of a protein27,28(see ﬁgure 2.6). Most of the time, when
domain motion occurs, the internal conformation of the domain remains the
same, whereas the conformation of the protein is changed. Large moves are
part of the activation process of most cellular proteins. However such reor-CHAPTER 2. PROTEIN STRUCTURE 11
Figure 2.5: Superimposition of active (blue PDB code 2C5P) and inactive
(red PDB code 1PXM) structures of the CDK2 kinase.
ganisations occur mostly on the  -second time scale and undergo signiﬁcant
conformational rearrangement (more information on loop and domain reor-
ganisation is in chapters 6 and 7). Investigating such reorganisations is of
important biological interest and could lead to an increase of the eﬃciency
of targeting speciﬁc conformational states. To be able to design a drug as
selective as possible to bind its target, a perfect understanding of the activa-
tion pathway is needed. However this knowledge is actually one of the main
challenges in molecular modelling. Classical methods fail to reach such aims.
Owing to time scale problems, the MD simulation is not capable of sampling
such large scale motions. However, the MD technique is usually chosen over
MC to simulate proteins even though there are no absolute rules(see refer-
ences30 and31 for examples of studies using the Monte Carlo method). The
Monte Carlo method fails to sample such changes too. However, speciﬁc al-CHAPTER 2. PROTEIN STRUCTURE 12
Figure 2.6: The LID domain of the Adenylate Kinase is in an open confor-
mation, if no ATP is bound to the active site (red). The LID domain closes
(dark blue) when an ATP molecule binds to the active site29.
gorithms to model large backbone moves will enable us to sample large scale
displacements and increase the backbone sampling. However, is the sampling
provided by these novel methods for MC simulations enough to sample large
scale reorganisation?CHAPTER 2. PROTEIN STRUCTURE 13
2.3 More to protein-ligand binding
Ligand binding is not just a matter of change in the shape of the protein
structure. The whole process of computing the binding free energy of a ligand
involves several enthalpic and entropic contributions from the ligand, the
protein and the solvent32–34. All these terms represent the work necessary
to move a ligand from the bulk (solvent) into the solvated binding pocket
(including desolvating the binding pocket). Such terms are represented in
table 2.2. Depending upon the nature of the ligand and the residues involved
Enthalpic terms (∆H) Entropic terms (∆S)
New solute-ligand interaction Protein degrees of freedom
Change in ligand/protein structure Ligand degrees of freedom
Ligand desolvation Ligand desolvation
Protein/complex desolvation Protein/complex desolvation
Table 2.2: Enthalpic and entropic contribution to the protein/ligand binding.
in the binding mechanism, the enthalpic or entropic contributions can have
great inﬂuence upon the binding. Binding processes can be enthalpy driven or
entropy driven and there is no absolute rules to predict a priori the binding
aﬃnity between a receptor and a ligand. However, the use of computational
methods can approximate the estimation of the binding free energy.
The next section will give details on the theory behind molecular dy-
namics and the Monte Carlo method and the thermodynamics beyond the
estimation of absolute and relative binding free energy.Chapter 3
Standard methods for
molecular modelling
This chapter brieﬂy overviews MD and MC theory. For further interest, refer-
ences 17,35–38 can be consulted. Other methods such as scoring functions and
docking will be brieﬂy described, and theories and equations beyond implicit
solvation and free energy perturbation will be detailed.
Molecular modelling simulation is a technique for computing the equi-
librium and transport properties of many body systems. The nuclear con-
stituents of the system, are modelled to obey to the law of classical mechanics
in terms of forces and energy (hence the name of molecular modelling).
3.1 Potentials and force ﬁelds
To model the behaviour of a biological system using the law of classical
mechanics, a set of parameters and equations used to model the real system
has to be built. This set of parameters and equations is referred to force ﬁeld.
The basic functional form of a force ﬁeld encapsulates both bonded terms
relating to atoms that are linked by covalent bonds, and non-bonded (also
called ”non-covalent”) terms describing the long-range electrostatic and van
der Waals forces. Force ﬁeld parameters are derived from experiment and/orCHAPTER 3. STANDARD METHODS FOR MOLECULAR
MODELLING 15
high-level quantum mechanical calculations.
The most popular forceﬁelds in biological simulations are the AMBER39–41
(developed to model DNA and protein), CHARMM42,43 (developed to model
proteins), GROMOS44 (developed to model condensed phase of alkanes) and
OPLS45 (developed to model physical properties of liquids) forceﬁeld. They
are all-atom force ﬁelds, where every atom including the hydrogen is repre-
sented, but some can use the united atom model. The speciﬁc decomposition
of the terms depends on the force ﬁeld, but a general form for the total energy
in an additive force ﬁeld can be written as:
Etotal = Ebond + Eangle + Edihedral + Eelectrostatic + EvanderWaals (3.1)
For the AMBER39–41 force ﬁeld the individual constituents can be expressed
as follow:
Ebond =
 
bonds
Kr(r − req)
2 (3.2)
Eangle =
 
angles
Kθ(θ − θeq)
2 (3.3)
Edihedral =
 
dihedrals
VN
2
[1 + cos(nφ − γ)] (3.4)
Eelectrostatic =
 
pairs
qiqj
4πǫ0r
(3.5)
EvanderWaals =
 
pairs
4ǫ
  σ
r
 12
−
 σ
r
 6 
(3.6)
Bond and angle parameters are described as simple harmonic oscillators
with a force constant and an equilibrium position, dihedral parameters by
a Fourier series with coeﬃcients (VN), dihedral angle (φ) and a phase (γ).
Non bonded interaction are treated through the use of a Coulombic potential
(Equation 3.5) depending on the atomic charges and the distance between
the two atoms of a pair, and through a Lennard-Jones (LJ) potential for theCHAPTER 3. STANDARD METHODS FOR MOLECULAR
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van der Waals interactions (Equation 3.6). Force ﬁelds are parametrised to
reproduce experimental results (such as hydration absolute free energies) and
quantum results.
3.2 Molecular Dynamics
In molecular dynamics simulations, we choose a system with N particles and
we solve Newton’s equations of motion for this system until the properties of
the system no longer present a drift with time (equilibration period). Then af-
ter equilibration, measurement of the physical properties is performed. New-
ton’s laws postulate that:
• A body continues to move in a straight line at constant velocity unless
a force acts upon it.
• Force equals the rate of change of momentum.
• To every action there is an equal and opposite reaction.
Solving the diﬀerential equation embodied in Newton’s second law (F = ma)
gives us the trajectory:
d2xi
dt2 =
Fxi
mi
(3.7)
Equation 3.7 describes the motion of a particle of mass mi along one coordi-
nate (xi) with Fxi being the force applied on the particle in that direction.
The ﬁrst molecular dynamics simulation was performed in 1957 using a hard
sphere model for the pair potential46. A more realistic approach consists of
using a continuous potential. The force of each particle will change whenever
the particle changes its position or whenever a particle with which it interacts
changes position. The problem is that the continuous potential for a multiple
body system makes the integration analytically impossible for system with
more than two bodies. To solve this, the integration is broken into small steps
each separated in time by a time step δt. The total force on each particle in
the system at the time t is calculated as the vector sum of its interactionsCHAPTER 3. STANDARD METHODS FOR MOLECULAR
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with the other particles. Newton’s second law is used to calculate the acceler-
ation from the forces. Accelerations are combined with position and velocities
at the time t to compute the change in the conﬁguration and to obtain the
coordinates and the velocities at the time t + δt. This process is repeated
iteratively until the end of the simulation. This value of δt captures all the
changes in the degrees of freedom of the system, and forces or potential are
conserved. The force F i applied at a particle i at the time t depends on the
potential energy V i of this particle:
F i = −∇riV i (3.8)
So a classical MD algorithm could be written:
• Get the coordinates and the velocities of all the particles of the system.
• Compute the potential energy and get the force for each particle.
• Use the coordinates, velocities and the force of each atom to get the
new sets of coordinates and velocities.
• Repeat.
At each step all the interactions, velocities and positions have to be recom-
puted which makes this method very expensive in CPU time. However the use
of speciﬁc algorithms such as the velocity Verlet47, described in the equations
3.9 to 3.11 enables faster computations.
r(t + δt) = r(t) + δtv(t) +
δ
2
t
2a(t) (3.9)
v(t + δt) = v(t +
δt
2
) +
δt
2
a(t + δt) (3.10)
v(t +
δt
2
) = v(t) +
δt
2
a(t) (3.11)
The velocity Verlet algorithm47 manages the explicit velocities of all the con-
stituent of the system. This algorithm is time reversible. To conserve energyCHAPTER 3. STANDARD METHODS FOR MOLECULAR
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during the integration, the time step has to be used in such way that the
forces remain approximately constant. To keep the forces constant, the cor-
rect time step δt to use for a protein system is 1 fs, so the fast vibration
of the bonds involving hydrogens can be sampled accurately. Computational
time can be gained by using the SHAKE48 algorithm to constrain bonds in-
volving hydrogen, allowing the time step to be increased from 1 to 2 fs and
hence halving the time of the computation. But, despite the use of such algo-
rithms, simulations for more than 1 ms on a large protein are not tractable
in a human time frame due to the cost in computer time.
3.3 Metropolis Monte-Carlo Method
The Monte Carlo method was developed at the end of the second world war.
This statistical method is based on the generation of an important quantity of
random numbers like in the casinos (hence the name from the Principality in
the south of France famous for its casino) to solve conformational problems.
Statistical mechanics aims to explain thermodynamics of an ensemble
(macroscopic properties e.g. temperature, pressure etc) by collecting the me-
chanical properties of the constituent of the ensemble (microscopic proper-
ties such as atomic positions or velocities). It all started with the law of gas,
PV = nRT from Boyle in 1661, but during the nineteenth century an uneasy
feeling was growing among the scientiﬁc community as to whether or not the
model would be able to explain individual atomistic properties∗.
Collecting a set of data for all the constituents of a macroscopic ensemble
is usually very costly due to the curse of the dimensionality. This can be
explained very simply by the following analogy.
Considering a unit sphere of dimension k (hypercube). The volume of the
∗Gibbs stated in the introduction of his book Elementary Principles in Statistical
Mechanics.49: The laws of thermodynamics, as empirically determined, express the ap-
proximate and probable behaviour of systems of a great number of particles, or, more
precisely, they express the laws of mechanics for such systems as they appear to beings
who have not the ﬁneness of perception to enable them to appreciate quantities of the
order of magnitude of those which relate to single particles, and who cannot repeat their
experiments often enough to obtain any but the most probable results.CHAPTER 3. STANDARD METHODS FOR MOLECULAR
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sphere is given by the formula:
V =
 
S
dx1...dxk (3.12)
whose solution is:
V =
πk/2
Γ(k
2 + 1)
(3.13)
Γ being the gamma function.
A solution of equation 3.12 using quadrature methods can be obtained by
computing the ratio of the sphere and its bounding cube. It leads to the
reformulation of equation 3.13 as:
I =
V
VR
=
 
[−1,1]k IS(x1,...,xk)dx1,...,dxk
 
[−1,1]k dx1,...,dxk
(3.14)
The function IS(X) takes the value 1 if X belong to the sphere or 0 if X
belongs to the cube but not the sphere.
To approximate the solution of 3.14, a uniform lattice of point spread over
[−1,1]k is built. Then the integrand over the [−1,1]k interval is averaged.
For a lattice of m points per dimension a total number of mk points have
to be sampled. The number of points required to compute the average of
the integral, increases exponentially with the number of dimension of the
hypercube. For the unit cell a lattice with a 0.01 mesh will require 100 points,
for a circle (k = 2) 10000 points are needed, and for a sphere one million
points are needed. Now to obtain the same 0.01 lattice spacing for a 1010
hypercube, 1020 sampling points will be required.
Rather than using quadrature, one way to estimate the quantity I would
be to use the Monte Carlo method38 where instead of m points for each
dimension k, a total of N point are randomly spread across the hyper cube
([−1,1]). The solution to the equation 3.14 can be estimated by the averageCHAPTER 3. STANDARD METHODS FOR MOLECULAR
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of all the points:
Iest =
1
N
N  
i=1
IS(Xi) (3.15)
Where for an ergodic system, the limit of Iest when N → ∞ is I. We can
calculate the volume of the [−1,1] box for the dimension k as 2k. The value
of the ratio of the sphere and its bounding cube I becomes then:
I =
V
VR
=
πk/2
Γ(k
2 + 1)2k (3.16)
The ratio I is now easily computed and values are plotted table 3.1
k V
VR
1 1.00 × 100
2 7.85 × 10−1
3 5.24 × 10−1
10 2.49 × 10−3
100 1.87 × 10−69
Table 3.1: Ratio of the sphere to
its bounding cube V
VR for diﬀerent
dimensions
We can see the problem of the Monte Carlo method with a large number of
degrees of freedom (typically sampling a protein). Most of the point are taken
outside the sphere of interest (in this particular example, sphere having both
a practical and metaphorical meaning). If we want to use the Monte Carlo
method to sample a general property A of a given system ε of N particles,
we are likely to experience the same limitations:
 A ε =
 
A(r
N)ρǫ(r
N)dr
N (3.17)
where ρǫ(rN) is the probability of the system being in the conﬁguration rN.CHAPTER 3. STANDARD METHODS FOR MOLECULAR
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According to the Boltzmann distribution, this probability in the canonical
ensemble (NVT) can be expressed as:
ρNV T =
exp(−βU(rN))  
exp(−βU(rN))drN = Z
−1exp(−βU(r
N)) (3.18)
where β = 1/kβT and Z is the conﬁguration integral over all the ensemble
 
exp(−βU(rN))drN. The term U(rN)) is the energy of the system in the
state rN. Using a Boltzmann distribution, the ratio of high energy states
over the low energy states is such that most of the conﬁgurations gener-
ated at random are located in the region of the phase space where the sys-
tem has high energy conﬁgurations (corresponding to non-physical conﬁgu-
rations) and thus contributes near to zero to the integral Z (in the case of
the hypercube most of the sampling was performed outside the sphere).
To be able to use the Monte Carlo method to solve chemical problems,
the method has to be adapted. A method developed by Metropolis et al.17,38
called Metropolis Monte Carlo, biases the generation of conﬁgurations to-
wards those that make the most important contributions to the conﬁguration
integral, those being the lower energy conﬁgurations.
The Metropolis Monte Carlo method uses an importance sampling tech-
nique in which the use of a distribution function ρ(x) allows function evalu-
ation to be concentrated in the region of space that makes important contri-
butions to the integral (i.e. low energy conﬁgurations). In the simple Monte
Carlo integration method, states with both high and low energy are gen-
erated with equal probability and then a weight of exp(−U(rN)/kβT) is
assigned to them for the calculation of properties in the canonical ensem-
ble. In the Metropolis scheme, the states are generated with a probability
of exp(−U(rN)/kβT) and each is counted equally. The Metropolis algorithm
generates a Markov chain of states which satisﬁes the two following condi-
tions:
• Each outcome depends only on the previous one.
• Each trial belongs to a ﬁnite set of possible outcomes.CHAPTER 3. STANDARD METHODS FOR MOLECULAR
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Suppose that the system is in state m, the possibility of jumping to the state
n is the N × M transition matrix πmn. The probability of a system being in
a particular state is represented by the vector ρ:
ρ = (ρ1,ρ2,...,ρm,ρn,...,ρN) (3.19)
Thus, the probability for an initial randomly chosen conﬁguration ρ(1) to
jump into a second state ρ(2) is given by:
ρ(2) = ρ(1)π (3.20)
The probability of the nth state is:
ρ(n) = ρ(n − 1)π = ... = ρ(2)π
(n−1) = ρ(1)π
n (3.21)
and the limiting distribution for a Markov chain is given by:
ρlimit = lim
n→∞ρ(1)π
N. (3.22)
When this limit is reached, we can now write the reverse distribution con-
dition: ρlimit = ρlimitπ. This means that for an equilibrium ensemble, each
element of the probability vector must satisfy the following condition:
 
m
ρmπmn = ρn (3.23)
The transition matrix π gives the probability of jumping from one conﬁgu-
ration to another (n → m). This probability can be given by multiplying the
probability of making a move from a state n to state m (αnm) by the prob-
ability of accepting this trial move (acc(n → m)). The matrix A (called the
underlying matrix) is directly related to the new trial conﬁguration pathway.
Assuming that the stochastic matrix A is symmetrical (i.e. the probability of
a jump from n to m is the same as that from m to n), owing to the conditionCHAPTER 3. STANDARD METHODS FOR MOLECULAR
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above, we can now write:
ρ × πnm = ρ × πmn (3.24)
ρn × αnm × acc(n → m) = ρm × αmn × acc(m → n) (3.25)
αnm × acc(n → m)
αmn × acc(m → n)
=
ρm
ρn
(3.26)
Using the Boltzmann equation for canonical ensemble, we can now express
the famous Metropolis criterion as:
acc(n → m) = min(1,exp(−β(U(m) − U(n)))) (3.27)
So a typical Monte Carlo algorithm would be described as follows:
• Collect the structural information and compute the energy of the sys-
tem in state n
• Perform random moves on degrees of freedom to get the new conﬁgu-
ration m
• Collect the structural information and compute the energy of the sys-
tem in state m
• Perform the acceptance test:
– If (U(m)) is lower than (U(n)) accept the move
– If (U(m)) is greater than (U(n)) accept the move according to 3.21.
Chose a random number between 0 and 1. If the random num-
ber is smaller than exp(−β(U(m) − U(n))) reject the move and
keep the conformation n. If the random number is greater than
exp(−β(U(m) − U(n))) accept the move and keep the conforma-
tion m
• Go back to the step one with the new conformation (n or m).
In Metropolis Monte Carlo, moving a single atom is not really a problem.
Using a cartesian frame of reference, a small change in the coordinates canCHAPTER 3. STANDARD METHODS FOR MOLECULAR
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give the new position of the atom:
xi′ = xi + δlx
yi′ = yi + δly
zi′ = zi + δlz
(3.28)
where δlx,ly,lz are randomly chosen in the range of δmax (adjustable parameter)
and the energy of the new conﬁguration is then calculated. For a small system
it is easy to generate a random conﬁguration, but for such systems as proteins,
owing to their complex structures, a special implementation must be used
for sampling a judicious phase space area.
3.3.1 Standard Protein sampling method
To sample proteins, speciﬁc methods have to be used. One cannot hope that
randomly moving cartesian coordinates will lead to a conformation that is
acceptable from an energetic point of view. Sampling protein can be separated
into sampling the side chains, or sampling the backbone.
Sampling the side chains is not very challenging. In both the widely used
MC package MCPRO50 and ProtoMS51 the thrashing method is used to
sample the side chains. This is done by small changes in the internal degrees
of freedom (dof) along the side chain. The values of bond angles and dihedrals
are changed in the Z matrix, and the cartesian coordinates are rebuilt. The
new conformation is accepted or rejected according to the Metropolis test17.
In most cases the χ angle is in this case considered as part of the side chain.
The thrashing method applied to side chains is fast and eﬃcient, as the
number of moving atoms is generally small.
However, sampling accurately the backbone is not as easy. In MCPRO50
the thrashing method is used (for more details about the possibilities of
MCPRO see reference52) to sample protein backbones, as well as transla-
tions and rotations of the cartesian coordinates. A Z-matrix is used to store
bond length, angle and dihedrals to be sampled. The value of one of the
previous dof is changed in the Z-matrix, the cartesian coordinates are re-CHAPTER 3. STANDARD METHODS FOR MOLECULAR
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built and the Metropolis test17 is performed using the potential energy of
the new conformation. This method is less computationally demanding than
MD simulations. The only changes in the potential energy are resulting from
the change in the dof, so the energy of only one length, one angle, or one
dihedral, has to be recomputed, as well as the moving non bonded interac-
tions. However, this method possesses some weaknesses. The most important
is a poor acceptance rate. If a dof is moved even by a small amount, atom
clashes may occur in a region far away as large displacements due to the
protein geometry occur. The other weakness is that most of the non bonded
interactions have to be recalculated after the move.
Figure 3.1: The four backbone atoms for two neighbouring residues are shown
above. The protein backbone-move moves the last three backbone atoms
bbatoms of one residue and the ﬁrst bbatom of the next residue. This is
because the moves assumes that these four bbatoms form a rigid triangle (as
is shown by the grey lines).
On the other hand, the ProtoMS package51 uses a rigid unit backbone
model for the protein. The rigid unit backbone is deﬁned by the rigid unit
made of the atoms C, Cα, and O of the residue i and the atom N of the
residue i+1. Moves assume this unit to be a rigid triangle, with the atom
C at its centre. The rigid unit can be rotated, translated, and every atom
attached to this unit will be rotated and translated as well. The rigid unit
backbone is presented in ﬁgure 3.1.
In ProtoMS51, the backbone and side chains can be moved independently
as well as the whole residue (backbone plus side chain). When a backboneCHAPTER 3. STANDARD METHODS FOR MOLECULAR
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move is performed, the internal dof are kept ﬁxed.
Moves as designed in ProtoMS51 are really localised. Very few internal
coordinates change at each step, so very few interactions have to be recom-
puted, which gives a noticeable gain in eﬃciency. These moves stretch bond
lengths and change the bond and dihedral angles of two residue. These moves
are accepted providing that the changes in bond length are not too important.
This is one of the main weakness of the method: the moves have to be close to
the previous conditions, and therefore, poor sampling of the conformational
phase space occurs.
3.4 Free energy method
The term free energy refers to the thermodynamic quantity of perhaps the
greatest importance for the chemist. This is because the value of the free en-
ergy gives direct knowledge of the direction of a reaction. The binding free en-
ergy for a host-guest system can be related to the strength (and the direction)
of the binding process. A negative binding energy will refer to a favourable
interaction, whereas a positive energy will refer to a non-favourable inter-
action. The bigger the absolute value of the binding free energy, the more
favourable (or non-favourable) the interaction is. In the canonical ensemble,
the Helmholtz free energy can be computed using the equation 3.29:
G = −kBTlnQ (3.29)
If the partition function is the NPT ensemble rather the the canonical en-
semble, G would be the Gibbs free energy. The partition function necessary
to compute the free energy is a function of the exponential energy of all the
possible conﬁguration Γ of the system35:
Q =
 
Γ
exp
 −E(Γ)
kBT
 
(3.30)CHAPTER 3. STANDARD METHODS FOR MOLECULAR
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This equation adopts at the limit the form:
Q =
1
N!
1
h3N
 
exp
 −E(Γ)
kBT
 
dΓ (3.31)
This equation is valid as a classical limit of the partition function. N is the
number of atom of the system and h is Planck’s constant. The total energy
E(Γ) can be express as the sum of the potential energy Ep function of the
coordinates q and the kinetic energy Ek function of the momentum p. Thus
the equation 3.31 can be rewritten:
Q =
1
N!
1
h3N
 
q
 
p
exp −
 Ep(q) + Ek(p)
kBT
 
dpdq (3.32)
Momenta and coordinates of a system are independent so the kinetic and
potential part of the partition function can be separated, and the partition
function can be express as the product of both energies.
Q =
1
N!
 
p
exp(
−Ek(p)
kBT
)dp
1
h3N
 
q
exp(
−Ep(q)
kBT
)dq (3.33)
= QkQp (3.34)
The potential energy partition function cannot be solved analytically due
to the large number of internal and external energy terms that needs to be
computed. The evaluation of Qp can be performed analytically (analytical
solution for the kinetic partition function can be found using the particle
in the box model35). Most of the time, the factor 1
h3N is dropped, and the
conﬁguration integral Z is deﬁned instead as:
Z =
 
q
exp(
−Ep(q)
kBT
)dq (3.35)
the integral function Z is still very diﬃcult to compute. Owing to the high
dimension of Z (N) the numerical integration converges slowly for systemCHAPTER 3. STANDARD METHODS FOR MOLECULAR
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such as a protein35.
3.4.1 Free energy perturbation
Absolute free energies, are most of the time used in the context to compare
two diﬀerent system, typically answering the question: does a molecule A
interact better with our receptor P than the molecule B? So rather than
computing the two diﬀerent absolute free energies, it is easier to compute
the relative free energy ∆GA→B between the two systems. This was ﬁrst
performed by Zwanzig in 195453.
∆GA→B = GB − GA
= (−
1
β
lnQB) − (−
1
β
lnQA)
= −
1
β
ln
 QB
QA
 
= −
1
β
ln
 
 
exp(−βUB(rN))drN
 
exp(−βUA(rN))drN
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multiply by 1 = exp(−βUA(rN))exp(βUA(rN)) gives:
= −
1
β
ln
  
exp(−βUB(rN)) × exp(−βUA(rN))exp(βUA(rN))drN
 
exp(−βUA(rN))drN
 
= −
1
β
ln
  
exp(−βUA(rN)) × exp(−β(UB(rN)) − UA(rN))drN
 
exp(−βUA(rN))drN
 
= −
1
β
ln
  
exp(−βUA(rN))
QA
× exp(−β(UB − UA)(r
N))dr
N
 
= −
1
β
ln
  
πA(r
N) × exp(−β∆UAB(r
N))dr
N
 
= −
1
β
ln
 
exp(−β∆UAB(r
N))
 
A
(3.36)
So the relative free energy is the ensemble average of the exponential of
the Boltzmann weighted diﬀerence between the two potential UA and UB. A
method called Free Energy Perturbation is used in computer simulation to
solve the Zwanzig equation. At each step i (or t in the case of MD) the value
of the of the quantity exp(−∆UAB(i)/kBT) is accumulated, and averaged at
the end of the simulation. The problem with solving equation 3.36 is that
the two potentials have to be located in a region of the phase space close to
each other. Problems occur when the two conﬁgurations are located in two
diﬀerent regions of the phase space. For example, if the phase space of low
energy states for B are located in the region of high energy states for A,
then the relative free energy ∆GA→B is likely to be over estimated, as the
potential UA will not generate enough conﬁgurations corresponding to the
potential UB. If the potentials are switched, the relative free energy ∆GB→A
will be over estimated as well. The diﬀerence between the two values of the
free energy is referred to as hysteresis. The larger the hysteresis, the more
inaccurate the calculation of the energy will be.
However, the relative free energy is a state function and thus only de-
pends on the two states A and B. Diﬀerent pathways to join both states
do not change the value of ∆GB→A. So a simple solution is to imagine aCHAPTER 3. STANDARD METHODS FOR MOLECULAR
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pathway linking the two states A and B in such way that the hysteresis is
minimised. Generally a multi-stage calculation is implemented using the cou-
pling parameter λ to deﬁne intermediate states (potentials) UP(λ) between
the potentials UA and UB, see ﬁgure 3.2. So the relative free energy ∆GB→A
Figure 3.2: New pathway using a multi-stage calculation process.
can be rewritten as the sum of the diﬀerences:
GB − GA = ∆G =
1  
λ=0
−kBTln exp(−∆U
′)/kBT λk (3.37)
where ∆U′ = UP(λk+1) − UP(λk).
3.4.2 Thermodynamic integration
Another way to access to the relative free energy is to compute the numerical
integral of the free energy gradient (∂G
∂λ). This method is called thermody-
namic integration (TI)35. The gradient (
∂G
∂λ)λ is estimated (numerically or
analytically) for each λ during a set of simulation run at diﬀerent λ. Once
known, the free energy gradient is integrated to yield to the relative free
energy along the λ coordinate:
Gλ=1 − Gλ=0 =
  1
0
 ∂G
∂λ
 
λ
dλ (3.38)CHAPTER 3. STANDARD METHODS FOR MOLECULAR
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The trapezium rule is often use to evaluate the integral and access the relative
free energy35. The free energy gradient is equal to the ensemble average of
the potential:
  1
0
 ∂G
∂λ
 
λ
dλ =
  1
0
 ∂U
∂λ
 
λ
dλ (3.39)
For a forceﬁeld the gradient can be evaluated by calculating the gradient
of each term directly with respect to λ. The ﬁnite diﬀerence (∆G
∆λ)λ can be
calculated as an alternative of the gradient. For each lambda, the evaluation
of the Zwanzig equation for a reference state λ should lead to the same
energy for both the forward and backward estimates (respectively λ + ∆λ
λ − ∆λ), provided ∆λ is small enough and the number of steps is such that
the Zwanzig energy has converged.
Both free energy perturbation and thermodynamic integration are known
to reproduce accurately some experimental results on a broad range of sys-
tems30,54–56.
3.4.3 Replica Exchange Thermodynamic Interaction
Novel methods have been implemented to enhance the accuracy of the ther-
modynamic integration method, inspired by generalised ensembles and called
Replica Exchange Thermodynamic Integration57,58 (RETI). RETI considers
the Hamiltonians of the system for diﬀerent coupling parameters λ to be part
of the same generalised ensemble. Hence it is possible to connect to diﬀerent
λ in a free energy simulation. During a RETI simulation, a set of replicas that
cover the range of λ are run, and periodically, moves between the replicas i
and j of the Hamiltonians HA and HB are performed. Moves are accepted
according to the test
exp
 
β(EB(j) − EB(i) − EA(j) + EA(i))
 
≥ rand(0,1) (3.40)
where EB(j) and EB(i) are the Hamiltonian of the state B for the replicas i
and j, and EA(j) and EA(i) are the Hamiltonian of the state A.CHAPTER 3. STANDARD METHODS FOR MOLECULAR
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The RETI simulation has little extra-cost over a standard thermodynamic
integration or free energy perturbation simulation, as all the replicas already
exist for the simulation. RETI provides enhanced sampling, as the method
allows the diﬀerent trajectories to access regions of the phase space that
would otherwise be in-accessible. For example when one λi exchange with a
λj located in a region of the phase space separated by a high energy barrier,
performs some local sampling and then ”jump back” to the original side of
the energy barrier the RETI simulations allow all the replica to sample the
high energy conﬁguration thus enhancing the sampling.
3.5 Temperature replica exchange
Owing the nature of the Metropolis test17,38, an increase of temperature is
likely to lead in an increase of the acceptance rate and hence an increase in
the exploration of the energy surface.
Ideally the same level of sampling would beneﬁt simulation run at stan-
dard temperature (298K) but due to the ruggedness of the potential energy
surface, systems can get trapped into a local energy minimum. A simple and
eﬃcient way to achieve eﬃcient sampling is to run parallel tempering (PT)
simulations59,60. The idea of PT is to perform several concurrent simulations
of diﬀerent replicas of the same system at diﬀerent temperatures and to ex-
change replicas between simulations i and j with probability:
p = min(1,exp(−(βj − βi)(Ei − Ej))) (3.41)
where βi = 1/kbTi and Ei are the inverse temperatures and energies of the
conformations respectively.
3.6 Modelling solvent
Most biological systems exist in an aqueous environment. To be realistic,
computer simulations have to reproduce the eﬀect of the solvent. The most
obvious representation is an explicit solvation where each molecule of solventCHAPTER 3. STANDARD METHODS FOR MOLECULAR
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is represented and interact with the system in a discrete fashion61–64. Using
an explicit model of solvent, although probably accurate, means that most
of the time thousands and thousands of new molecules (and their relative
interactions) need to be computed, and most of the CPU time is used to
re-compute solvent interactions:
• at each step all solute/solvent and solvent/solvent non bonded interac-
tions for moving atoms needs to be re-computed.
• after a solute move, the solvent need to be reorganised around the
solute.
• presence of the solvent may render large conformational changes diﬃ-
cult if not almost impossible.
The Generalised Born (GB) model is used to model a continuum dielectric
potential to represent the solvent65. The electrostatics for a charged sphere
q, dielectric constant ǫvac and a radius α can be expressed as:
Gvac =
q2
2ǫvacα
(3.42)
In a dielectric medium with a dielectric constant of ǫsolv, the total electrostatic
energy is shown to be:
Gsolv =
q2
2ǫsolvα
(3.43)
The diﬀerence between 3.43 and 3.42 expresses the electrostatic energy
needed to transfer a spherical charged ion of radius α from a medium with
a dielectric constant ǫvac to another with a dielectric constant ǫsolv. This is
known as the Born equation65:
∆GBorn = (
1
2ǫsolv
−
1
2ǫvac
)
q2
α
(3.44)
If we assume the protein to be composed of charged spheres with a charge
qi, a radius αi and an interior dielectric of ǫi, then providing we can assumeCHAPTER 3. STANDARD METHODS FOR MOLECULAR
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each atom to be distant enough to the other, then the sum of the coulombic
interaction and the Born solvation energy can be written:
∆Gtot =
1
2
 
i
 
i =j
qiqj
ǫsolvrij
−
1
2
(
1
ǫvac
−
1
ǫsolv
)
 
i
q2
i
αi
(3.45)
Unfortunately, equation 3.45 is not valid for pairs where the radius αi and
the distance rij are too close. The Coulombic interactions can be split in
two66:
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This equation can be rewritten:
∆Gtot =
1
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Where ∆GGENBORN is:
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The quantity αi of the equation 3.44 is replaced by the values Bi and Bj.
The diﬃculty of equation 3.48 lies in computing the value of the Born radii
Bi. Its value is not αi and it is inﬂuenced by its surroundings. The original
work from Still66 uses a numerical method to compute the value of the Born
Radii Bi:
• Consider a shell of thickness Tk surrounding the van der Waals surface
of atom k.
• Weight the interior radius (rk − 0.5Tk) of this shell using the ratio of
solvent accessible surface area Ak to the actual surface area.CHAPTER 3. STANDARD METHODS FOR MOLECULAR
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• Repeat the weight for the exterior radius (rk+0.5Tk) and calculate the
diﬀerence between weighted interior and exterior radii.
• Sum the diﬀerence between weighted interior and exterior radii for a
series of concentric shells up to shell M which encompasses the whole
of the van der Waals surface of the molecule.
• For shell M no weight is applied and the radius is simply added to the
previous summation term, to obtain an eﬀective Born radius, which is
then used in equation 3.48
This method is very costly. The use of an analytical method such as the
Pairwise De-screening Approximation (PDA) developed by Hawkins et al 67,68
makes the computation of the Born radii quicker.
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Lij = 1 if Rij + Sijαj ≤ αi
Lij = αi if Rij − Sijαj ≤ αi < Rij + Sijαj
Lij = Rij − αj if αi ≤ Rij − Sijαj
Uij = 1 if Rij + Sijαj ≤ αi
Uij = Rij + Sijαj if αi < Rij + Sijαj
Rij is the distance between the two spheres centred on atoms i and j and
αi the intrinsic born radius of the atom i. The PDA approximation tends
to overestimate the Born radius. So the screening factor Sij is introduced
to correct for the over-estimate by scaling the Born radius. This means the
scaling factor should have a value between 0 and 1.
However it would be wrong to only consider the GB equations, as deﬁnite
”answers” to the solvation problem. Solvation not only deals with charges,
but also volumes. So to solvate a solute, a cavity has to be formed (disturbing
the hydrogen bonding network in the case of water) and solvent molecules
have to reorganise around the solute. Solute atoms interact with solventCHAPTER 3. STANDARD METHODS FOR MOLECULAR
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atoms, thus forming repulsive or attractive van der Waals interactions (owing
to the solute-solvent distance, such interactions are mainly attractive).
Both eﬀect are taken into account using a solvent accessible surface area
(SASA) term for the solute66,69.
Gnonpol = Gcav + GvdW =
N  
k=1
σk.SASAk (3.50)
The SASA is the surface ”ﬁlled” by the solute that is non-accessible for
the solvent. Water molecules are approximated to spheres with a 1.4˚ A radius,
and such a sphere is rolled over the van der Waals surface of the solute to
approximate the SASA. One of the drawbacks of the method is that the water
sphere can only roll on the solute atoms on the outside. Thus buried atoms
are not taken into account to build the SASA whereas they do interact with
explicit solvent.
Combining both methods is referred as Generalized Born Surface Area
(GBSA)69. Parametrisation of an accurate GBSA model is obtain by re-
producing the experimental absolute hydration energy of ions and small
molecules69.
3.7 Virtual screening in computational chem-
istry
In the constraints of the pharmaceutical world, one would like to be able to
virtually screen several thousand of compounds per day. However a such task
is not feasible using rigorous methods.
Usually, to be able to sample several thousands of compounds a day
some level of precision has to be sacriﬁced to the beneﬁt of speed. The use
of docking and scoring functions to rank the aﬃnity of a broad set of ligands
to a known structure is widely used in the pharmaceutical world70.
Numerous number of docking algorithms are available for free or a nom-
inal fee (in a review from Taylor et al. from 2002, 127 algorithms are men-CHAPTER 3. STANDARD METHODS FOR MOLECULAR
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tioned70) each having its strenghts and weaknesses. Popular algorithms are
Autodock71, Gold72 or Flexx273,74. Rather than describe each algorithm, the
general principles of docking and scoring functions will be described in the
following sections.
3.7.1 Docking
Docking is a computational method used to rank the aﬃnity of ligands to-
wards a speciﬁc 3D structure of a receptor. To be able to dock a ligand to
a protein the structure of the receptor has to be suggested, and then the
diﬀerent ligands are docked into the receptor.
The docking process aims to explore translational and rotational degrees
of freedom of a given ligand within the receptor. An ensemble of ligand
conformations is generated as the docking proceed. The receptor is usually
considered rigid. To perform the generation of the diﬀerent conformations,
Monte Carlo methods, genetic algorithms or incremental construction can be
used.
The energy of the diﬀerent conformations of the protein-ligand system is
then approximated using a scoring function. The section below will describe
how to approximate the energy.
3.7.2 Scoring functions
Scoring functions are computed using the sum of empirical terms associated
to the diﬀerent degrees of freedom:
∆Gbinding = ∆Gsolvent + ∆Gconformation + ∆Gintermolecular + ∆Grotation
+∆Grotation/translation + ∆Gvibration
However, the use of empirical terms to approximate the diﬀerent energetic
terms does not yield to exact ranking. Terms such as the entropic penalty of
desolvation are usually badly represented or even neglected in the use of a
scoring function. A study from Michel et al. compares the results of ranking
a set of ligands using various docking algorithms and RETI and shows that
scoring function methods do not yield a ranking as good as thermodynamic
methods57.CHAPTER 3. STANDARD METHODS FOR MOLECULAR
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3.8 Concluding remarks
There are no strict rules regarding which method is to be applied to sample
the conformational phase space of a system. Most of the time, common sense
and experience leads to the choice of one method.
Owing to the time scales, sampling phenomena such as large conforma-
tional changes in proteins using MD is non tractable in human time. However,
enhanced MD techniques could lead to a good sampling of such moves. The
other possibility is to use equilibrium techniques such as MC. Sampling large
moves using standard MC and explicit solvation is ineﬃcient, so the use of an
implicit solvation and speciﬁc algorithm to enhance the sampling are needed.
The following chapter will review several sophisticated implementations
used in MC simulations to sample polymers and proteins.Chapter 4
Non time-dependent move for
polymers and proteins
Polymers are of great industrial importance. Theoretical studies under dif-
ferent conditions (temperature, density, chain lengths) may oﬀer valuable
insights in understanding their behaviour75.
Several algorithms for sampling the conformational space of polymers
exist. Lattice and oﬀ-lattice models of polymers such as the crankshaft76,
the reptation moves77,78 or general bias algorithms79–81 are widely used for
polymers but are not eﬃcient for heteropolymers such as proteins. New local
or concerted moves82–86 are more appropriate to sample moves of protein
backbones.
4.1 Algorithms for polymer sampling
Using a lattice-polymer allows several simple moves, from the random walk
to the Verdier-Stockmayer algorithm using a combination of several other
moves (crankshaft, kink jump and end rotation)76. Schemes for the diﬀer-
ent moves are represented in ﬁgure 4.1. Sampling polymers is usually time
consuming, due to physical properties (i.e. the chain cannot cross itself) and
real motion algorithms will suﬀer from ineﬃciency. Random walk algorithmsCHAPTER 4. NON TIME-DEPENDENT MOVE FOR
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(a) Representation of a random
walk move.
(b) Representation of a self
avoiding walk move.
(c) Representation of a repta-
tion move.
(d) Representation of the Verde
algorithm.
Figure 4.1: Scheme of several lattice Monte Carlo moves for polymers36.
(ﬁgure 4.1(a)), change the lattice occupation of the polymer and most of-
ten lead to non-physical conﬁgurations, as nothing stops the polymer from
”walking” onto itself.
To solve this problem, a set of constraints needs to be imposed (self
avoiding walk moves 4.1(b)). This has been described ﬁrst by Rosenbluth79.
The use of the Rosenbluth sampling79 to create polymer chains has solvedCHAPTER 4. NON TIME-DEPENDENT MOVE FOR
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the ineﬃciency in polymer sampling. The Rosenberg scheme aims to insert a
polymer is a two step approach. First, a new conformation of the chain is gen-
erated by biasing the coordinates in such way that the polymer cannot cross
itself. Next, the bias is corrected by re-weighing the system. In the original
scheme a chain is rebuilt step by step with a bias favouring the conforma-
tions with a high Boltzmann factor. Then once the chain is totally rebuilt,
detailed balance is fulﬁlled by a conformation-dependent weight applied to
correct the bias. This method, although correct in theory, practically works
mainly for short chains. One other possibility is to use the conﬁguration bias
Monte Carlo method (CBMC) (see ref79–81,87) that biases the chain towards
low energy states (and thus avoiding crossing as high energy barriers).
Both methods are used in a rebuilding fashion often called reptation (the
chain is locally rebuild at each step and the acceptance test is performed
at the end), and can be applied to lattice as well as non-lattice models of
polymers.
Kick jump and crankshaft (see ﬁgures 4.1(c), 4.1(d)) involve changes in
dihedral and angles along the polymer chain. For the crankshaft it is easy
to imagine a car crankshaft pushing the pistons up and down by rotating
around an axle, main axis of rotation if ﬁxed, but some parts of the crank
undergo large moves rotating around the axle (pushing the piston up and
down). Same happens here, the bond between two atoms (atoms 3 and 4 in
ﬁgure 4.2) rotate around the adjacent parallel bond (bonds 1-2 and 5-6 in
ﬁgure 4.2).
The kick jump move involve jumping from one corner of the lattice to the
opposite one, changing the appropriate degrees of freedom (dof ). Both the
kick jump and the crankshaft can be used on and oﬀ lattice.
From the geometric construction of the previous algorithms, one can ﬁnd
very little use for these moves to sample proteins. For example, the repta-
tion move only works in a case of a mono-residue protein. Crankshaft and
kink jump would lead to steric clashes if applied in the protein core or bind-
ing pockets. Sampling proteins therefore requires speciﬁc moves. The section
below investigates a few of the speciﬁc algorithms for proteins.CHAPTER 4. NON TIME-DEPENDENT MOVE FOR
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Figure 4.2: Representation of the crankshaft move88. The thin red line rep-
resents the rotation axis.
4.2 Algorithms for protein sampling
The concerted-rotation approach is a powerful method that can generate
large local deformations by ﬁnding discrete solutions to the re-bridging prob-
lem described by Go and Schegara89. However, the method is not easy to
implement and large local deformations may be diﬃcult to accomplish if, for
example, the chain is folded and has bulky side groups. The ﬁrst mention of
solving ring closure problems in a polymer chain was provided by Go and
Schegara82, but this method did not conserve the metric volume and hence
failed to satisfy detailed balance. The algorithm by Dodd et al.82 uses a
jacobian matrix to conserve the metric volume and the detailed balance cri-
terion, and is known as the concerted rotation algorithm, also referred to as
CONROT. Other concerted algorithms exist, such as the concerted rotation
with angles CRA83, the gaussian bias90, the lmProt algorithm91, the wrig-
gling motion92,93, algorithm using rectangular shape models94,95, algorithms
derived from robotics96–101 or the PAR-ROT algorithm102. These algorithmsCHAPTER 4. NON TIME-DEPENDENT MOVE FOR
POLYMERS AND PROTEINS 43
will be brieﬂy described to give the reader an overview of the state of the art
of sampling protein loops.
4.2.1 Non-Boltzmann weighted algorithms
The chain closure problem is well known in the ﬁeld of robotics. The robot
arm is a single chain consisting of joints connected by links. The ﬁrst and
last elements of the chain are special; they actually are not considered joints
and are called the base and the eﬀectors (see ﬁgure 4.3).
Figure 4.3: Representation of the robot arm96.
The analogy of the robot arm and the protein is easy to understand; an atom
between two bonds in the protein is represented by a joint connecting two
links together in the robot arm. Then a frame of reference is attached to each
joint/bond of the chain (see75 for more details). In the paper by Lee et al.96
the loop closure is solved by using the jacobian matrix relating the change of
the eﬀector position due to changes in the joints75,96. The algorithm works
in the following way:
• An external force is applied to break the loop.
• The loop is closed by the use of the internal attractive forces. Clos-
ing the loop in such peculiar cases, means connecting the base to the
eﬀector where the loop has been broken.CHAPTER 4. NON TIME-DEPENDENT MOVE FOR
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This algorithm does not take into account steric clashes so this method is
unable to solve complex loop motion. Other algorithms such as the random
loop generator (RLG)99,100 or the rapidly-exploring random trees (RTT)98 use
a probabilistic road map (PRM) approach to solve the ring closure problem101.
The PRM algorithm, is a two step algorithm. First, a road map is built and
stored as a graph with nodes corresponding to collision free conﬁgurations,
and edges as path between the nodes. Second, the base and the eﬀector of
the robot, are connected to two nodes of the road map, and then the road
map is search for a path linking the two nodes. The RLG algorithm does
not suﬀer from the clash problem, as the algorithm is built in such way that
the robot arm does not collide with itself or any other solid object. So the
constraints are set when the mapping is built (in this case, distances between
atoms shorter than 70% of their van der Waals radii are to be avoid). The
RLG algorithm keeps both bond length and bond angles ﬁxed and rebuilds
the loop by avoiding collision at each node along the road map (further
information can be found in references99,100). The RLG algorithm has been
tested on several systems such as the endo-β-1,4-xylanase protein and has
been proved to give good sampling of the loop.
The RTT method incrementally grows a random tree rooted at the initial
conformation that explores the reachable conformational space and ﬁnds a
feasible path to connect the goal conformation. The RTT algorithm is also
coupled with elastic network normal mode analysis103 or EN-NMA. This
method drastically reduces the number of dof to explore. The search space
of the RTT algorithm does not lie in the molecular conformational space of
all the dof (i.e. the torsion angles), but only in the phase space of the low
frequency normal modes from the EN-NMA. Vibrational modes given by the
EN-NMA are only valid around the initial conformation and the RTT search
would not be accurate when exploring larger regions. So the EN-NMA has
to be regularly updated during the conformational change to generate the
correct low-frequency vibrational modes. The RTT and RLG algorithms use
connectivity matrices to solve the dependencies of the end base of the arm
with respect to the joints (here the moving joints are the dihedral angles).CHAPTER 4. NON TIME-DEPENDENT MOVE FOR
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Another algorithm from the robotics ﬁeld has been proved to be eﬃcient
in solving the chain closure problem. It is referred to as the cyclic coordinate
descent CCD104. The CCD is a loop builder algorithm where the loop is built
in such a way that the three backbone atoms (N, Cα and C) of the last loop
residue (i.e. C anchor) are superimposed with the goal conformation (see ﬁg-
ure 4.4).
Figure 4.4: Representation of the anchors and the vectors for the CCD algo-
rithm104.
As shown in ﬁgure 4.4,
− →
f1,
− →
f2, and
− →
f3 are vectors that represent the ﬁxed
target positions for the atoms of the C-terminal residue of the loop. The
positions of the moving C-terminal residue atoms are represented by M01,
M02, M03, and M1, M2, M3, before and after a change, respectively, in a
dihedral angle of any residue in the loop. The rotation axis (containing O1,
O2, O3) is given by the direction of the bond corresponding to the dihedral
angle that is modiﬁed (N-Cα for φ , Cα-C for ψ ), where O1, O2, and O3
are the footpoints of vectors from the rotation axis to the three atoms of
the moving C-terminal anchor. The CCD rebuilds the loop by iteratively
changing the random values of the dihedral angles φ and ψ of the backboneCHAPTER 4. NON TIME-DEPENDENT MOVE FOR
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chain until the loop is closed. Closing the loop means minimising the distance
S:
S = |
− − − →
F1M1|
2 + |
− − − →
F2M2|
2 + |
− − − →
F3M3|
2 (4.1)
A Ramachandran map for the diﬀerent rotamers of the angles φ and ψ of the
chain is built so a constraint can be added to the system. For each residue of
the loop, the angle φ is built by solving equation 4.1 (for more details on how
to solve this equation see reference104) and then the new angle ψ is build
according to the Ramachandran map. The new φ,ψ pair is then accepted
with a probability of 1 if the new pair is more probable, or a probability of
pnew/pold if the new pair is less probable then the old one in the Ramachan-
dran map. However, the literature quotes the Ramachandran mapping to
have no noticeable eﬀect on the closure of the loop104. One extension to the
CCD algorithm is the full cyclic coordinate descent or FCCD by Boomsman
et al 86. This method uses both bond angles and dihedrals to solve the loop
problem, but instead of considering the whole atomistic chain, the algorithm
is computed between the Cα. The distance between two Cα is kept ﬁxed at 3.8
˚ A, and instead of rotating the end anchor around an axis, the Cαs are used
as centre of rotation. The end tail anchor, is also made of three consecutive
Cαs, rather than three consecutive atoms. This is the only diﬀerence between
the CCD and the FCCD. They work in a very similar fashion, changing every
dof along the chain so that the distance S between the goal and the tail an-
chors is minimised. One disadvantage of the CCD methods is to induce large
changes in the pseudo angles at the start of the loop and small ones at the
end. The FCCD algorithm has the possibility to perform the pivot selection
in a random fashion (choosing randomly which pair of angles φ,ψ is used to
minimise S), so that the diﬀerence in the value of the changes in the pseudo
angles is not localised at the beginning of the chain.
One other algorithm called the wriggling92,93 uses a concerted motion
and some geometrical properties of vectors to ”wriggle” four dihedral at the
same time in a protein backbone. The ”wriggling” relies on the fact that for
four vectors − → v 1,− → v 2,− → v 3,− → v 4in the three dimensional space there is a linearCHAPTER 4. NON TIME-DEPENDENT MOVE FOR
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combination of these four vectors, whose sum is equal to zero:
4  
i=1
xi− → v i = 0 (4.2)
This condition is used to produce a change in the [−0.0125,0.0125] radian
range of four dihedrals, in such way that the change remains local (for more
details see references92,93). This method has been tested using at 0 K, to see
if it could fold a protein with more eﬃciency than the standard thrashing
method. It is not clear due to the temperature (the test is hence a min-
imisation and not a simulation) and the energy function (a linear correlation
between the energy and the RMSD between the simulated protein and folded
structure) that the wriggling is much more eﬃcient that thrashing or other
concerted rotation algorithms.
Since all of the above algorithms do not really sample the phase space
of a protein loop, but rather build a loop conformation that avoids clashes
and links both ends of the loop. No energetic criterion is considered, and
the new conformation of the loop is never tested according to a Boltzmann
distribution. Choice has been made to focus on other types of concerted
rotation that respect detailed balance, speciﬁcally the CONROT, CRA and
gaussian Bias methods that will be described below.
4.2.2 Boltzmann weighted algorithms
The CONROT move performs local moves along a protein backbone by
changing dihedral angles in a concerted fashion. First, a driver angle called φ0
of a randomly chosen atom from all the coordinates is changed by a (random
or not) known small amount. Then a rearrangement of a minimum number
of neighbours is performed, keeping the preceding and the following atoms
in the chain ﬁxed. In moving the atoms in the neighbourhood of the driver
angle, both bond lengths and angles remain unchanged, and thus the only
degree of freedom allowed to move are the torsion angles. This kind of change
must be done using internal coordinates. The chain is then closed satisfyingCHAPTER 4. NON TIME-DEPENDENT MOVE FOR
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the constraints needed to keep the ends ﬁxed. The use of the driver angle, and
the geometry of the system give us that 7 dihedrals (φ0,φ1,φ2,φ3,φ4,φ5,φ6)
have to be changed to perform a move (see reference82 for more details).
The peptide bond dihedral is kept ﬁxed, so a minimum of nine atoms are
necessary to compute a concerted rotation move. The set of values for the
dihedrals can be expressed in the frame of reference of the ﬁrst atom of the
local chain (for details on frames of references see75)and we can now turn to
the problem of incorporating the concerted rotation move as an elementary
move within a MC algorithm. The conditions to close the chain are expressed
as a function of the ﬁrst dihedral, and the equation f(φ1) = 0 is analytically
solved. All the solutions for the forward Nn move are computed, one is ran-
domly chosen and the reverse solutions for the move Nm are computed. To
preserve the metric weight after the chain closure, the jacobian J = |
1
detA|
(where A is a geometric dependent matrix, with r5 the constraint geometric
vector, u6 the constraint unit vector, γ6 the constraint Euler angle vector and
e1 the unit vector∗) is computed.
A =
∂r5
∂φ1
∂r5
∂φ2
∂r5
∂φ3
∂r5
∂φ4
∂r5
∂φ5
∂r5
∂φ6
∂u6
∂φ1   e1
∂u6
∂φ2   e1
∂u6
∂φ3   e1
∂u6
∂φ4   e1
∂u6
∂φ5   e1
∂u6
∂φ6   e1
∂u6
∂φ1   e2
∂u6
∂φ2   e2
∂u6
∂φ3   e2
∂u6
∂φ4   e2
∂u6
∂φ5   e2
∂u6
∂φ6   e2
∂γ6
∂φ1
∂γ6
∂φ2
∂γ6
∂φ3
∂γ6
∂φ4
∂γ6
∂φ5
∂γ6
∂φ6
(4.3)
Then attempted probabilities for the move are calculated:
αn(m → n) = 1/N
n (4.4)
αm(n → m) = 1/N
m (4.5)
∗the values of the vectors r5 and u6 are refered as the vectors s and u respectively in
ﬁgure 4.6CHAPTER 4. NON TIME-DEPENDENT MOVE FOR
POLYMERS AND PROTEINS 49
and the probability to accept the ﬁnal move is:
acc(n → m) = min
 
1,
Nmexp(−U(n)/kβT)J(n)
Nnexp(−U(m)/kβT)J(m)
 
(4.6)
where Jm and Jn are the jacobian for the foward and reverse move respec-
tively.
A method described by Farvin et al. makes use of a biased gaussian step
in order update the conformational sampling of the protein90. Small steps
are taken, so that large local deformation cannot take place. For a set of
local deformations in the dihedral angles δ¯ φ = (δφ1,...δφn) a conformation-
dependent n × n matrix called G is introduced. The matrix G has to fulﬁl
the condition that:
δ¯ φ
TGδ¯ φ ≈ 0 (4.7)
The steps δ¯ φ are then drawn from a gaussian distribution:
P(δ¯ φ) ∝ exp
 
−
a
2
δ¯ φ
T(1 + bG)δ¯ φ
 
(4.8)
where a and b are tunable parameters. The parameter b controls the force
of the gaussian bias whereas the parameter a controls the acceptance rate.
For large b, the bias is really strong, and disappears in the limit b → 0. The
probability of the attempted move is:
W(δ¯ φ
′ → δ¯ φ) =
det(
a
2(1 + bG))
π3 exp[−(δ¯ φ
′ − δ¯ φ)A(δ¯ φ
′ − δ¯ φ)] (4.9)
To move from the conﬁguration δ¯ φ to a new conﬁguration δ¯ φ′ the acceptance
test has to be modiﬁed so as not to break detail balance. The new acceptance
test is now:
Pacc =
 
1,
W(δ¯ φ′ → δ¯ φ)
W(δ¯ φ′ → δ¯ φ)
exp[(E
′ − E)/kT]
 
(4.10)
Where the factor
W(δ¯ φ′→δ¯ φ)
W(δ¯ φ′→δ¯ φ) is the bias of the move necessary to keep theCHAPTER 4. NON TIME-DEPENDENT MOVE FOR
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detail balance criterion.
This move uses the Gausssian bias to move a set of diherdals. Such move
is faster than CONROT moves as:
• the reverse move does not need to be performed to compute the accep-
tance test (see below)
• no chain closure is performed.
The concerted rotation with angle algorithm (CRA) performs local moves
along the protein backbone. The CRA move involves two steps. The ﬁrst is
a prerotation move using a gaussian bias on all the degrees of freedom (both
bond and dihedral angles, in blue in ﬁgure 4.5) followed by a chain closure
move (in red ﬁgure 4.5). Both ends of the chain remain ﬁxed to keep the
move local (in black in ﬁgure 4.5). Mathematical details can be found in
reference83. The derivatives of the cartesian coordinates of the atom a with
N
C s
v
u
a
C
N N
N
C
C
Figure 4.5: Scheme of the Concerted Rotation with Angle move
respect to the n degrees of freedom (dof ) are calculated to build a n × 3
matrix. Then this matrix is squared to obtain the n × n matrix I:
Iij =
  ∂a
∂φi
.
∂a
∂φj
 
(4.11)
Then the matrix J = c1(1 + c2(I × I)) is calculated (were 1 is the identity
matrix). The parameters c1 and c2 control respectively the acceptance rate
and the force of the bias. The bias aims to minimise the displacement of the
atom a such that : d2 = (δa)2. The Cholesky decomposition of the matrix
J is used to calculate the matrix L. Then a set of n random numbers δχCHAPTER 4. NON TIME-DEPENDENT MOVE FOR
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following a gaussian distribution are used to solve the equation:
δχ = L
tδφ. (4.12)
where the vector δφ represents the changes in the dof. The random gaussian
vector δχ is built in such a way that the displacement d of the vector a is
minimised:
δχ
tδχ = d
2. (4.13)
Then the new conformation is built, using the new dof and the new matrices
I′J′L′ are recomputed. Using the linear transformation:
δχ
′ = L
′tδφ. (4.14)
the values of δχ′ and d2 = δχ′tδχ′ for the reverse move are calculated and
the biasing probability for both forward and reverse move can be expressed:
P(a → b) = (detL)e
−d (4.15)
P(b → a) = (detL
′)e
−d′
(4.16)
The matrix L is a lower triangular matrix so its determinant can be easily
calculated by :
detL =
 
i
Lii (4.17)
In the original reference83, moves are limited to 9 dihedral angles, but nothing
stops the move from being longer or shorter, as the method can in principle
work with any number of dof.
Once the prerotation move is complete, the second part of the move is
computed. A scheme of the notation used in the chain closure can be found in
ﬁgure 4.6. To close the chain, several constraints have to be respected. The
position of the last atom s and the orientation of the vectors u and v have
to be kept ﬁxed which gives us 3 constraints for the condition on the atom s
and 3 other constraints on the vectors u and v (for more detail see referenceCHAPTER 4. NON TIME-DEPENDENT MOVE FOR
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Figure 4.6: Scheme of the Chain Closure algorithm83
83). To be able to solve the chain closure and to satisfy the set of constraint,
6 dof have to be moved. Three dihedrals (peptide bond dihedral being kept
ﬁxed) and three angles are moved to solve the geometric problem. Using 3×3
matrices to perform rotations along bond (T) and dihedral (R) angles and
to change of frame of reference the equation below has to be solved:
R
−1
3 T
−1
2 R
−1
2 T
−1
1 R
−1
1 T
−1
0 u =



cosα3
sinα3
0


 (4.18)
Using the change in frame of reference we can now express each dof as a
function of the ﬁrst dihedral ω1.
We use the matrices corresponding to the rotation along the bond angle
αi and the rotation along the dihedral ωi, respectively Ti and Ri, (for more
details about frames of reference see the Nobel Price lecture by Flory75)
which are deﬁned as:
Ti =



cosαi −sinαi 0
sinαi cosαi 0
0 0 1


 (4.19)CHAPTER 4. NON TIME-DEPENDENT MOVE FOR
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Ri =



1 0 0
0 cosωi sinωi
0 −sinωi cosωi


 (4.20)
So the z-axis component of the right end side of the equation 4.18 is equal
to zero. So the left hand side can be numerically solved as a one unknown
equation, G(ω1) = 0 and the others dof can be calculated with respect to
ω1.
The equation 4.18 has only two branches instead of 4 for the CONROT,
and there is no need to perform a reverse move anymore (this is due to the
mathematical construction of the move). This method is currently about four
times faster than the original CONROT (for more details see references82,83)
in terms of speed for the closure of the chain.
Many other algorithms and methods that satisfy detailed balance are
available for sampling proteins such as LmProt91 or the Parrot102 algorithm.
To be able to sample loop motions with a good eﬃciency, the gaussian Bias
and the CRA methods have been investigated, and implemented in an exist-
ing molecular modelling package. Both methods satisfy detailed balance and
hence can be used to perform MC simulations. Some applications of these
concerted motions can be found in the section below.
4.3 Applications for proteins
The CONROT method can be used either for folding105,106 or for energetic
studies30,107. In the case of protein folding, good agreement with experimental
data (NMR) has been found even for small cyclic peptides. In this case,
the use of MC moves aims to lead to the true, cis/trans population of the
amide bond. In ﬁve diﬀerent peptides, the MC simulations lead to the same
conﬁgurations as the experimental data (even with a boat like conﬁguration
leading to a cis-trans-cis-trans sequence). The CONROT method has also
been used in the investigation of nucleic acid and small protein folding106.CHAPTER 4. NON TIME-DEPENDENT MOVE FOR
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The eﬃciency has been calculated using the formula below:
sw = lim
h→0
nσ2 (A) n
nσ2(A)
(4.21)
where A is the observable value (the energy, the Ramachandran angles or
any other physical property), σ2(A) the variance, and σ2 (A)  is the variance
average for windows of length n. The algorithm has been used on a small
protein (65 residues), the chymotrypsin inhibitor 2 (CI2) and a 12 nucleotide
ribosomal RNA hairpin whose sequence was (GGGCGAAAGCCU)106. The
results show the eﬃciency of CONROT moves to sample all the phase space
for the protein with a reduction in computational time. The simulations
on the nucleic acid lead to the same conclusion; good eﬃciency (close to the
result obtained with MD simulations) and a reduction in computational time.
CONROT has also been used to sample phase space for free energy per-
turbation studies107. The algorithm can perform better sampling of the phase
space and hence obtain more precise free energies during the simulation. This
enhanced sampling leads to very eﬃcient results with small calculated stan-
dard errors. This study shows the eﬃciency in using the CONROT algorithm
for the investigation of the binding free energy of a host-guest system107. The
relative binding free energy of three amino acids for macro-bicycle 12 in chlo-
roform were calculated. The eﬃciency of CONROT moves to perform large
conformational changes in the hydrocarbon segments allowed accurate sam-
pling of the host, and lead to free energy values close to experiment.
The CRA algorithm, despite being a quite recent method, has been used
eﬃciently with both proteins and nucleic acids84,108. This method has been
ﬁrst tested by calculating the average dihedral step size per local move84,85:
|sw| =
   
 
  1
nω
nω  
i=1
(δωi)2 (4.22)
and the statistical eﬃciency sw of the sampling of the main chain dihedralCHAPTER 4. NON TIME-DEPENDENT MOVE FOR
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angles
sw = lim
n→0
nσ (A) n
nσ(A)
(4.23)
where A = cosωi is the observable main-chain dihedral angle. The systems
used for the test were tetradeca-alanine and a 36-residue peptide taken from
the villin headpiece sub domain.
Both simulations were performed using OPLS-AA force ﬁeld in vacuum at
30 ◦C . A more realistic series of runs were performed in an implicit solvent
model (GB/SA) using the (Ala)8, (Ala)10, (Ala)12 as benchmarks for the
algorithm. The study showed a good agreement between the CRA and the
preceding studies using both MD and MC. Another study on a small system,
β-Hairpin U(1-17)T9D derived from a globular protein, shows the eﬃciency
of this method. The study shows a clear relationship between the number
of H-bonds, RMSD of the backbone and the energy. The conformation of
the low temperature converged structure was close to the NMR determined
conformation.
The CRA algorithm has also been used in the folding of nucleic acids84. As
in the studies of proteins, the use of CRA in both vacuum and GB/SA against
a modiﬁed CONROT or a local update of the main chain torsion angles,
showed the eﬃciency of CRA. CRA allows for more sampling of the main
chain conﬁguration than the CONROT algorithm. This is due to the fact
that the CRA algorithm is more eﬃcient in sampling all the conformational
ﬂexibility of the main chain as both bond and dihedrals angles are changed.
The use of the gaussian bias for the ﬁnal displacement of the prerotation
move, also increases the sampling as the method achieves a very good closure
rate.
The CRA algorithm has been compared to MD simulation108 in a pro-
tein folding investigation. Thus both methods lead to conformations close to
experimental native states for three diﬀerent peptides and MC simulations
tend to be 2-2.5 times faster than MD simulations.CHAPTER 4. NON TIME-DEPENDENT MOVE FOR
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4.4 Concluding remarks
As described in chapters 2 and 3 biological processes involving major reor-
ganisation of protein structures occur in a time scale too long to be sampled
using MD. Using MC method to sample such large moves involves the use
of speciﬁc algorithms. Many algorithms exist that generate loop or random
conﬁgurations of a polymer or a protein.
Moves used for polymers cannot be used in proteins due to the non-
homogeneity of biological systems. Moves inspired from robotics give good
results in closing the loop. However, to be used during a MC simulations,
moves have to comply with the detailed balance criteria and most of the
loop closure algorithms inspired from robotics introduce a bias that cannot
be corrected and hence, break detailed balance.
To sample large scale motion of proteins, Boltzmann weighted algorithms
need to be used. The CRA algorithm has been described to enhance sampling
of protein backbone loop and in several case to be faster than MD methods.
Owing the ﬂexibility of of several class of protein, choice has been made to
implement it in the ProtoMS package51 to use it on protein-ligand interaction
problems.
Details of the implementation of the CRA in ProtoMS, are described in
the next chapter.Chapter 5
Software Development
This chapter describes the overall work of implementing the CRA algorithm
in the ProtoMS51 package. First a summary of the capabilities of the ex-
isting packages will be discussed, then a section on how the CRA has been
implemented and then enhanced in the ProtoMS51 package, will be discussed.
5.1 Existing Monte Carlo simulation package
The ProtoMS51 package (locally developed in Southampton) does not per-
form concerted motion moves, whereas the MCPRO package50 incorporates
the concerted rotation with angles algorithm in addition to standard thrash-
ing moves (see 3.3.1 for a description of the thrashing move). However, the
MCPRO50 package is slower than the ProtoMS51 package, less user friendly,
and the CRA algorithm is not modiﬁable in terms of its parameters or struc-
ture. Ideally we would like to have the best of both i.e. having a ﬂexible CRA
algorithm in the ProtoMS51 software.
The MCPRO package does not handle the PDB format as input. Instead,
a speciﬁc tool called pepz has to be used52 to generate a Z-matrix, making
the use of MCPRO50 less intuitive and more fastidious. The user of pepz need
to know the sequence of the protein. In ProtoMS51, a pdb ﬁle can be used asCHAPTER 5. SOFTWARE DEVELOPMENT 58
the standard input ﬁle with no need to create the Z-matrix. MCPRO50 has
been used to obtain benchmarks for the tryptophan protein (see ﬁgure 5.1).
To get the optimum combination of ProtoMS51 and both the CRA and the
Figure 5.1: 3-D representation of the Tryptophan zipper protein (PDB refer-
ence: 1le1)
gaussian bias algorithms, a good understanding of the code is needed. This
understanding has been achieved through the use of the simulations and some
small modiﬁcations of several routines (see 5.2).
5.2 Eﬃciency of existing methods.
Standard MC and MD simulations have been performed on two diﬀerent
systems, the chicken villin protein, and the ala-(14) polypeptide in both linear
and α-helical conformations, to get conformational sampling data. To checkCHAPTER 5. SOFTWARE DEVELOPMENT 59
the implementation of CRA in ProtoMS51, the tryptophan job from the test
section of the CPRO50 has also been run.
5.2.1 Classical MD and MC simulations.
For each system, a 2.4 ns MD simulation has been performed using the AM-
BER package and force ﬁeld39,109, the SHAKE algorithm48 to constrain the
bonds, at 300 K temperature. The MD simulation has been performed in
both vacuum and the GBSA implicit solvent model67,68. For both chicken
villin protein (PDB reference 1yu8) and the α-helix polypeptide ala-(14)
(build using the molden110 package) the same equilibration process has been
used. First, 1000 steps of minimisation were performed, followed by 10 ps of
dynamics both with 5 kcal/˚ A2 restraints applied to the atoms of the system.
Then the same process was repeated with 1 kcal/˚ A2 restraints. Then 1000
steps of minimisation and 10 ps dynamics without any restraints ended the
equilibration period. The 2.4 ns production trajectory was generated for each
of the two systems using randomised velocities. The analysis of speciﬁc items
of the trajectory was made using the ptraj tool of the AMBER package to
compute the RMSD with respect to the ﬁrst structure of the trajectory.
Monte Carlo simulations have been carried out using the ProtoMS51 soft-
ware. Simulations have been run at 298 K and using constant volume and
temperature conditions. A ﬁrst period of equilibration of 5000 MC steps is
carried out, and then a 100000 MC step simulation is performed. The aver-
age acceptance rates for the MC simulation are displayed table 5.1. Table 5.1
shows that the acceptance rate for the backbone moves are poor (around
2.56% for the polypeptide and 1.1% for the chicken villin protein). The size
of the move is between 0 and 2 ˚ A for the translations and between 0 and 0.5
radians for the rotations for the rigid units (see ﬁgure 3.1 and section 3.3.1).
Such low rates indicate that the backbone sampling is poor and that most
of the phase space sampling is due to side chain moves (in the case of the
polypeptide, the moves are actually quite small considering the geometry
of the side chain). The acceptance rates for backbone moves are about ten
times smaller than the total acceptance rate. An increase of the acceptanceCHAPTER 5. SOFTWARE DEVELOPMENT 60
ala(14)polypeptide chicken villin
GB 22.92% 2.64% 14.63% 1.26%
Vacuum 22.76% 2.53% 14.61% 1.13%
Table 5.1: Acceptance rate during the MC simulations for the linear polypep-
tide and the chicken villin protein. Backbone (blue) and complete molecule
(red) in both vacuum and GB.
rate will be possible by allowing smaller amplitude to the move. However,
that would lead to smaller sampling, and the computational time needed to
sample a given phenomenon would increase dramatically.
If we compare the values of the RMSD with respect to the ﬁrst structure
for both MD and MC, we can clearly see that standard MD is more eﬃcient
in terms of sampling than classical MC. The RMSDs are plotted in table 5.2.
Value of the RMSD for the MD simulations of the ala(14)polypeptide are two
ala(14)polypeptide chicken villin
Vacuum 0.07±0.03 5.64±1.00 1.16±0.18 3.04±0.27
GB 0.08±0.03 2.50±0.47 1.08±0.16 3.40±0.92
Table 5.2: RMSD of the backbone for MD (blue) and MC (red) in both
vacuum and GB. RMSD are express in ˚ A with standard deviations for blocks
of 1000 MC steps given.
order of magnitude bigger than the RMSD for the MC simulations. Values
of the RMSD for the MC simulation of the chicken villin protein are about
one third of the value of the RMSD for the MD simulations. The very poor
sampling of the ala(14)polypeptide is due to the linear form of the polypep-
tide. The sampling achieved with the classical MC method clearly shows the
need for novel sampling algorithms for protein backbones. A third simulationCHAPTER 5. SOFTWARE DEVELOPMENT 61
Figure 5.2: Sampling of standard MC moves on a linear ala(14) polypeptide.
Simulation have been carried on for 1000000 steps and snapshots taken every
10000 steps. Using rigid unit backbone moves as describe chapter 3.3.1
using a linear ala-(14) polypeptide has been performed. Figure 5.2 shows the
superposition of snapshots of the backbone along the MC simulation. This
ﬁgure clearly shows the ineﬃciency of the rigid backbone unit to sample large
scale moves on proteins, as very little deviation of the backbone geometry
occurs.
A good solution would be to have the CRA algorithm implemented into
the ProtoMS package51. The process about how the existing package has been
modiﬁed and how the CRA algorithm has been implemented in ProtoMS51
is described below.
5.3 Code implementation
To enhance the sampling of the protein backbone, the CRA algorithm has
been implemented in the ProtoMS51 package. Then the algorithm has been
modiﬁed in such a way that the length of the move could be adapted to the
biological problem. This scheme gave us several advantages:CHAPTER 5. SOFTWARE DEVELOPMENT 62
• Using the ProtoMS51 structure allows faster computations and a friendlier
interface.
• Using a modiﬁed CRA, allow the length of the move to be adapted to
the biological problem.
The ﬁrst step was to implement the original CRA algorithm from the MCPRO50
package into ProtoMS51.
5.3.1 Standard CRA into ProtoMS
The CRA code of the MCPRO50 package has been incorporated almost di-
rectly into ProtoMS51 to model biological targets and to implement the ex-
isting code. The original code for the CRA algorithm has been designed to
be used according to the reference83. The algorithm does not allow concerted
rotations to be performed on longer or shorter segment then a nine dihedral
segment of the protein backbone. The implementation of the CRA algorithm
into the ProtoMS51 code has been done in several stages.
• The ﬁrst step was to create a new movetype for ProtoMS51. New vari-
ables have been created and handle the new move, and the probabilities
of moves have been reassigned.
• ProtoMS51 uses rigid backbone unit moves. So, to be able to make the
changes in the internal dof, routines converting the cartesian coordi-
nates into internal degrees of freedom (bond length, bond and dihedral
angles) have been built. Cartesian coordinates of the atoms N, Cα and
C are stored, along with the bond lengths and angles.
• CRA moves are performed as described in the reference83.
• Energy is recomputed, and a new Metropolis Monte Carlo test is per-
formed including the bias of the prerotation move, and the Jacobian
for the chain closure.
The rebuilding of the protein and the way coordinates are stored in a stack
pile, have been modiﬁed in ProtoMS51 to manage the number of residuesCHAPTER 5. SOFTWARE DEVELOPMENT 63
involved in the concerted motion. The user can choose to perform either
the whole simulation using CRA, or to mix CRA with the standard moves
already available in ProtoMS. The use of the CRA move can be restricted to
a speciﬁc region of the protein (to sample only a speciﬁc loop for instance).
This allows greater ﬂexibility to perform more precise simulations.
To get as close as possible to the code described in the reference83, only
the ﬁrst part of the move is performed on the ﬁrst or last three residues of the
protein (i.e. only the gaussian bias90). This implementation allows a complete
sampling of the system, whereas the CRA algorithm by construction (both
ends of the rotated chain being kept ﬁxed), cannot move the ﬁrst and the
last residues of the protein and hence, folding would not be observed. From
this point, CRA moves will refer to moves as described in the literature83.
A complete scheme of the software design is presented ﬁgure 5.3 with the
blue square representing the implementation at this stage. So the ProtoMS51
package can run several moves from the same input:
• Standard ProtoMS51 moves using the rigid unit backbone moves.
• CRA moves as described in reference83 using a gaussian bias without
chain closure for both ends of the protein. The CRA moves can be
restricted to a speciﬁc region of the protein.
The results obtained in developing such moves for the ProtoMS51 package
are described below.
5.3.2 Standard CRA in ProtoMS: results
4 million step MC simulations have been run in implicit GBSA solvent on
both ala-(14) polypeptide and chicken villin headpiece protein to test the
eﬃciency of the CRA move implemented in ProtoMS51. Diﬀerent ratios of
CRA move have been tried: ﬁrst a ratio of one CRA move every four standard
moves (1/4 green and black curves), and then a ratio of one for two (1/2
red curve), standard moves being backbone, residue, and side chains moves
described in ProtoMS51.CHAPTER 5. SOFTWARE DEVELOPMENT 64
Figure 5.3: Scheme of the CRA implementation in ProtoMS. Both CRA
and standard moves can be performed as the same time, the length of the
prerotation move can be chosen, and a CRA only option can be used to
perform only CRA moves.CHAPTER 5. SOFTWARE DEVELOPMENT 65
While the use of CRA enhances the sampling (see ﬁgures 5.4 red and
green curve, for enhanced sampling of the polypeptide), both simulations
were unable to fold the protein. The RMSDs (with standard deviations)
with respect to the original structure are bigger than using standard moves.
RMSD for the simulation using a ratio of one CRA move for 4 standard move
is 2.85±0.63˚ A for the backbone only, and the RMSD for the simulation where
the ratio is one for two is 2.46 ± 0.68˚ A. In both case, the RMSD is of the
same order of magnitude as the RMSD from the MD simulation. RMSDs are
computed using the structures of the snapshots, obtained every 1000 steps.
Figure 5.4: RMSD of the ala(14) polypeptide using standard and gaussian im-
plementation of CRA moves in ˚ A. The red and green curve for the RMSD are
the RMSD obtained with CRA moves only. The black curve is the RMSD ob-
tained using CRA move and the gaussian bias for the ends of the protein (see
chapter 5.3.3. RMSD for the black curve is obtained after super-imposition
of the structures.
So far the ProtoMS51 package has been implemented with the CRA as
described in original reference83. This implementation allows the gaussianCHAPTER 5. SOFTWARE DEVELOPMENT 66
bias move on both ends of the protein (changing both bond and dihedral
angles) to be performed. The end move is not part of the sub-routine from
MCPRO50 but suc move is performed in MCPRO50. It has been implement
in ProtoMS51 in new routines. Details on the implementation of the end move
(gaussian bias) are described below.
5.3.3 Implementation of the gaussian bias in ProtoMS
Implementing the gaussian bias in the ProtoMS51 package aims to two goal.
First allowing end move for the protein and to later implement a extended
prerotation move for the CRA algorithm. To implement the gaussian bias into
the source code of ProtoMS51, the concept of frame of reference described by
Flory75 has been investigated and applied to calculate the matrix I and to
the rebuilding of the chain.
We have ﬁrst attempted to get the derivatives of the vector a (as described
in83) using the change of frames of reference. This change of frame of reference
allows us to describe a bond vector pi whose coordinates in the frame of
reference i are



pi
0
0


, in the frame of reference (i−1) by using two rotations
along the z and x axes. The matrices corresponding to the rotation along the
bond angle αi and the rotation along the dihedral ωi are respectively Ti and
Ri (for more details see75) which can be deﬁned as:
Ti =



cosαi −sinαi 0
sinαi cosαi 0
0 0 1


 (5.1)
Ri =



1 0 0
0 cosωi sinωi
0 −sinωi cosωi


 (5.2)
So the total transformation matrix changing the coordinates from the frameCHAPTER 5. SOFTWARE DEVELOPMENT 67
of reference i to the frame of reference i − 1 can be expressed as follows:



cosαi sinαi 0
−sinαi cosωi cosαi cosωi sinωi
sinαi sinωi −cosαi sinωi cosωi


 (5.3)
The vector of the coordinates of an atom ri can then be expressed in the
preceding frame of reference by using the relation
ri−1 = Ti−1Riri + pi−1 (5.4)
So the coordinates of the last atom of a chain can be expressed in the frame
of references of the ﬁrst atom of the chain and then using the transforma-
tion matrix Mlab the coordinates can be expressed in the laboratory frame
of reference (generally a cartesian space frame) by using a product of ma-
trices. These matrices only depend of one degree of freedom and so we can
diﬀerentiate the cartesian coordinates of the last vector, with respect to the
degrees of freedom.
To test the routines responsible of change of cartesian coordinates, an
initial algorithm was coded, fully independent of the CRA algorithm and the
ProtoMS51 package, in which a chain of atoms is built when the values of
the bond and dihedral angles are used as input. The ﬁrst atom has cartesian
coordinates of (0,0,0) and the second of (0,0,l) where l is the length between
the two atoms (length that for testing purposes is the same for all the atoms of
the chain). To test this ﬁrst step, the values of the coordinates of the resulting
chain have been compared to the coordinates obtained from ProtoMS51. The
use of such a frame of reference as the one described in the reference75 involves
changing the value of the dihedral angle n from φn to φn + π, when the
value of the bond angle n − 1 is greater than π. Then the derivatives of
the coordinates of the last atom with respect to the degrees of freedom are
computed. To test the derivatives of the position of a with respect to the
degrees of freedom using the matrices T and R from the reference75, the
numerical approximation of the derivative is calculated using ProtoMS51 byCHAPTER 5. SOFTWARE DEVELOPMENT 68
changing the value of one dof at each step. The formula for the numerical
approximation of the derivative of a function f(x) for the value of x = φi is:
lim
h→0
f(φi + h) − f(φ)
h
(5.5)
So computing the values of the coordinates for ﬁve dihedrals φ and using the
formula 5.5 we can compute an approximation of the values of the deriva-
tives. Theses values are compared to the values of ∂a
∂φi using the analytical
results. Then, in order to increase the accuracy of the results the numerical
approximation of the derivative is computed using :
lim
h→0
f(φi + h) − f(φi − h)
2h
(5.6)
Results of the numerical approximation and derivative method are show in
table 5.3. Table 5.3 shows that the values of the derivatives of the coordinates
Xa Ya Za
value of
the dof
∂a
∂φi Num
Approx
∂a
∂φi Num
Approx
∂a
∂φi Num
Approx
39 -1.389 -1.375 0.000 0.000 -0.611 -0.630
49 2.031 2.062 1.271 1.260 1.154 1.432
110 0.355 0.401 1.123 1.416 1.350 1.318
-110 -0.156 -0.115 1.039 1.033 -0.823 -0.859
153 -0356 -0.344 -0.400 -0.401 -0.288 -0.286
53 1.259 1.318 -1.620 -1.604 0.447 0.458
90 -0.248 -0.229 -0.786 -0.802 -0.946 -0.974
Table 5.3: Numerical approximation of ∂a
∂φi. Where Xa, Ya, Za are the values
of the derivatives of the vector a along the axes respectively X, Y, Z.CHAPTER 5. SOFTWARE DEVELOPMENT 69
of the atom a with respect to the degrees of freedom computed with the
use of Flory’s frame of references75 are close to the numerical approximation
using a value of h of 1◦.
Once the derivatives are computed, the matrices I, J, L as deﬁned in the
reference83 are built and the n gaussian numbers are randomly chosen, and
following the process described in section 4.2.2, the biasing probability is then
calculated for both forward and reverse moves. Each routine has been tested
separatly using simple matrices and the results have been double-checked by
hand. Once every routine has been tested and shown not to be faulty, the
complete prerotation move has been tested by computing 1 million steps of
Monte Carlo simulation. This test has been performed outside the ProtoMS51
package, with no energy function so only geometric changes were considered.
The distribution of both angles and dihedrals has been plotted by increments
in bins of 5 degrees and compared to the distribution obtained by using the
CRA algorithm from MCPRO83 incorporated in ProtoMS51 under the same
conditions (no energetic function). The test system is a linear ”phantom”
chain 6 dihedrals long. These results were obtained using the same parameters
c1 and c2 which control the acceptance rate and the size of the bias described
in reference83 for both simulations. Simulations have been repeated twice.
Figure 5.5 shows that for the two sets of data, the dihedral angels are equally
distributed between −π and π. The standard deviation of the distribution
are for both methods of the same order of magnitude and this shows that
the two methods are not signiﬁcantly diﬀerent. The prerotation move using
a gaussian bias can then be implemented in ProtoMS51.
Once the gaussian bias has been implemented in ProtoMS51, it is used
to move the ﬁrst two and the last three residues of the protein, so the CRA
moves in ProtoMS51 are now implemented as described in the original pa-
per83. RMSD for the simulation using the gaussian bias move for protein ends
is shown ﬁgure 5.4. If we compare the value of the RMSD (black curve in 5.4)
with the ones without the gaussian bias move for ends, it becomes obvious
that this implementation provides the necessary tool for protein folding.
The CRA algorithm has then been tested by comparing the tryptophan
(see ﬁgure 5.1) test job in MCPRO50 with the equivalent simulation usingCHAPTER 5. SOFTWARE DEVELOPMENT 70
Figure 5.5: Distribution of the 5 dihedrals used in the prerotation move. The
red curves represent the distribution obtained using the original CRA algo-
rithm incorporates in ProtoMS51. The black curves represent the distribution
obtained using the frame of references describe by Flory75 used to implement
the gaussian bias move for protein ends. All set of data were obtained during
a 10 millions steps MC simulation with no energetic potential.
ProtoMS51.
5.3.4 Gaussian bias implementation results
The extended tryptophan zipper protein has been used as starting conﬁgu-
ration for 2.5 million MC steps in GBSA, using both the ProtoMS51 and the
MCPRO50 packages. For the simulation run with ProtoMS51, the average
acceptance rate for the tryptophan protein is 8.72±4.87% whereas the total
acceptance rate for CRA moves is 7.57±3.57% (average over blocks of 50000CHAPTER 5. SOFTWARE DEVELOPMENT 71
MC steps). RMSD of both package with respect to both the folded and un-
folded structure is represented ﬁgure 5.6. Figure 5.6 shows that in both cases,
the RMSD with respect to the folded state gets smaller whereas the RMSD
with respect to the extended state gets bigger. This shows that the change in
the structure is toward the folded state. Not only do both simulations achieve
the same range of deviation of within 1 ˚ A, but the overall shapes of the curve
with respect to the folded state are similar. So the CRA implemented in the
ProtoMS51 package leads to the same results as the CRA in the MCPRO
package.
Figure 5.6: RMSD of the tryptophan zipper protein (PDB code 1le1) with
respect to the initial structure (solid) and the folded structure (dash). Black
curves are obtained using the MCPRO50 package, the red using the Pro-
toMS51 package.
Table 5.4 shows the values of the RMSD between the folded NMR struc-
ture and the last conﬁguration of both simulations. Values of the RMSD are
close to each other, showing similar behaviour from both packages.
The ﬁnal structure of the 2.5 million MC step simulation is shown inCHAPTER 5. SOFTWARE DEVELOPMENT 72
Backbone Heavy atoms All atoms
ProtoMS 6.6 8.5 8.9
MCPRO 6.2 7.6 8.2
Table 5.4: RMSD between the folded structure and the last step of the sim-
ulation. Structures are aligned on the NMR structure of the folded protein.
RMSDs are expressed in ˚ A.
ﬁgure 5.7. The ﬁnal conformations from both packages have been super-
imposed with the folded NMR structure.
The CRA algorithm has been implemented in the ProtoMS51 package
as described in the literature83. However, the use of the ProtoMS51 package
provide useful features that do not appear in the MCPRO package50 such as:
• the possibility to mix CRA moves, rigid unit backbone moves, side
chain moves
• the possibility to apply only the CRA move to a speciﬁc fraction of the
protein.
The implementation of the gaussian bias in ProtoMS51 for protein ends
uses an iterative algorithm which means that the gaussian bias can be ex-
tended to any number of dof or residues. So we have decided to implement
it with the chain closure algorithm move, so the CRA could be extended to
any length. This implementation will be describe below.
5.3.5 Extended concerted rotation moves
The use of the matrices T and R is slower than the algorithm used in the
CRA code to compute the derivatives of a (using cross product, see refer-
ence93 for some deﬁnitions), so the computation of the derivatives of the
atom a have been modiﬁed to use the cross product method. However the
iterative design is kept so the gaussian bias move can be extended to many
degrees of freedom. So the standard ProtoMS51 package features several im-
plementations:CHAPTER 5. SOFTWARE DEVELOPMENT 73
Figure 5.7: Snapshots of the last structure with MCPRO (blue) and ProtoMS
(green) for the Tryptophan zipper protein. NMR structure for the unfolded
protein is represented in red.
• Standard CRA algorithm from the MCPRO50 package into the soft-
ware, moving only 4 residues during the prerotation phase. Both ends
of the protein are moved using the prerotation move only (gaussian
bias move).
• Gaussian bias move without chain closure. No restriction on the length
of the moved segment.
• Gaussian bias move with the chain closure algorithm. No restriction
on the length of the moved segment, giving much more ﬂexibility thanCHAPTER 5. SOFTWARE DEVELOPMENT 74
standard CRA algorithm (for example useful to sample a 5 residue long
loop/chain).
The last two options are not available in the MCPRO50 package which
makes the ProtoMS51 software more adaptable to the various biological prob-
lems. Theses new implementations have been tested using a long linear poly-
alanine protein and results are described below.
5.3.6 Extended concerted rotation moves: Results
The speed of the original CRA move has been compared to the ProtoMS51
standard backbone move to yield the computing time per step in table 5.5.
The ﬁrst column shows the time ratio per move between standard backbone
move and CRA move in ProtoMS. Standard backbone moves are about 7
times faster (CRA is slower, but it moves 4 residues in a concerted fashion).
The second column shows the time ratio per residue between backbone moves
and CRA moves in ProtoMS. The CRA move appears to be less than twice
as slow per residue moved, but on the other hand has a better acceptance
rate. The last column show the diﬀerence in speed when the derivatives of
the atom a are computed in the original CRA algorithm implemented in the
ProtoMS package with respect to the speed when the same derivatives are
computed using the Flory frame of references. Flory’s frame of references is
slower as all the coordinates and the matrices has to be recomputed at each
step but both methods lead to the same results.
ratio time per
step
ratio time per
step per residue
ratio of the
derivatives
method
CRA
Move/ProtoMS
BB move
7.05 1.76 0.18
Table 5.5: Computing time comparison between the original CRA algorithm
and backbone moves in ProtoMS.CHAPTER 5. SOFTWARE DEVELOPMENT 75
To implement the prerotation move correctly, the original algorithm from
MCPRO50 implemented in ProtoMS51 is compared to the modiﬁed ver-
sion using the extended gaussian bias. Several parameters from reference83,
such as diﬀerent gaussian random number distributions (and consequently
d2 = (δa)2) have been generated along a million step MC trajectory of the
”phantom” chain. The distribution of d, of the vector δχ and the distance of
the prerotation move δa (distance of the atom a before and after the move)
have been plotted in ﬁgure 5.8.
(a) d (b) δχ
(c) δa
Figure 5.8: Distribution along a 1 million step trajectory, for the original
CRA code and the gaussian bias implementation (distance δa in ˚ A). The
black curves are obtained using the original CRA algorithm implemented in
ProtoMS51. The red curves are obtained using the cross product method.CHAPTER 5. SOFTWARE DEVELOPMENT 76
Two diﬀerent sets of simulations have been performed to test the variables
plotted in ﬁgure 5.8: a ﬁrst simulation using a set of numbers built from a
gaussian distribution, and a second one a set using a ﬁxed random seed. This
is to obtain the same series of gaussian number to generate the bias during the
prerotation phase. Both simulations lead to the same properties. Figure 5.8
compares the values of the original CRA algorithm and the modiﬁed gaussian
bias in the case where both algorithms are using the same seed. The values
drawn from the random distribution using the same seed are close one to each
other, so the recursive part of the algorithm that diﬀerentiates the coordinates
of the atom a can now be extended to more than 4 residues.
Simulations using a gaussian bias move (implemented in ProtoMS51) for
4 to 8 residues long have been run during 1 million steps in vacuum on the
ala(14) polypeptide. All moves start from the 3rd residue of the chain, with
the number of moving residue extended from 4 to 10. This aims to test the
extended gaussian bias in terms of acceptance rate. The distribution of the
distance between the atom a before and after the prerotation move is plotted
in ﬁgure 5.9. Figure 5.9 shows an increase in the distance the atom a is
moved during prerotation. As the number of residues increases, the number
of prerotation moves that are suﬃciently small to lead to a chain closure
decreases. Obviously, the longer the prerotation move, the more diﬃcult the
closure.
However, the use of gaussian bias on both bond and torsion angle but
without chain closure leads to good results in terms of enhanced sampling.
The c1 and c2 parameter for the acceptance rate and the force of the bias are
those used in the reference83. The acceptance rate per chain length are shown
in table 5.6. Table 5.6 shows clearly that the acceptance rate for the gaussian
bias moves decreases with the length of the chain. It has to be noticed, that
even with an 8 residue long chain, this implementation achieves a better
sampling and a higher acceptance rate then the rigid unit backbone moves.
So gaussian bias is a promising method to sample large scale motion. Being
able to close any chain length after a gaussian bias move and hence perform
a full CRA move should lead to even better results in terms of sampling.
The chain closure algorithm has been added to the extended prerotationCHAPTER 5. SOFTWARE DEVELOPMENT 77
Figure 5.9: Distribution of the length of δa for various chain length. The
distribution is obtained over a 100000 MC steps simulation.
number of
residue
4 5 6 7
acceptance
rate
32.85±3.38 21.99±2.39 13.98±1.50 9.92±1.10
number of
residue
8 9 10
acceptance
rate
7.65±0.83 6.42±0.70 5.75±0.62
Table 5.6: Acceptance rate for the gaussian bias move with no closure.
move. Several lengths of prerotation move have been tried with the chain
closure algorithm on a 32 residue long poly-ala using the amber force ﬁeld39.
Simulation were run in GBSA solvent for 100000 steps (100 block of 1000CHAPTER 5. SOFTWARE DEVELOPMENT 78
steps). Results of the diﬀerent simulations are reported table 5.7. In red
are reported the total acceptance rates (average of the total acceptance rate
per block), in blue, the acceptance rates without the end move (acceptance
rate over the whole simulation). So the use of the extended prerotation with
closure still gives a good acceptance rate even for long chains.
number of
residue
5 6 7 8 9
acceptance
rate 20.86 21.87 22.87 26.77 27.80
acceptance
rate 15.27 16.04 14.95 18.30 17.84
Table 5.7: Acceptance rate for extended prerotation with chain closure.
So diﬀerent possibilities are now available for the ProtoMS51 package,
most of them not present in MCPRO50:
• Standard ProtoMS51 move
• CRA move (as described in the reference83) on a random segment of a
protein
• CRA move (as described in the reference83) on a random segment of a
chosen loop of a protein
• Gaussian bias move of any length on a random segment of a protein.
• extended CRA of any length on a random segment of a protein
• extended CRA of any length on a random segment of a chosen loop of
a protein
• any of the previous mixed with standard ProtoMS moves
The CRA method has been used on the CDK2 kinase (see ﬁgure 5.10).
A 4 million step MC simulation has been carried out in implicit solvationCHAPTER 5. SOFTWARE DEVELOPMENT 79
without any ligand in the binding pocket. Regrettably, this simulation is
unable to give energetic information, as some parameters for the loop are
actually missing in the force ﬁeld and have for this purpose been estimated.
The CRA moves with standard length have been performed on the activation
loop only. The active conﬁguration is in blue. The inactive is in red. The cyan
conﬁguration is obtained after a 4 million steps MC simulation and the green
ones show the pathway along the trajectory starting from the active structure.
Owing to the diﬀerence between active and inactive forms of the protein and
Figure 5.10: Snapshot of the CDK2 simulation using a modiﬁed CRA. In blue
2c5p pdb database reference and in red the 1pxm pdb database reference.
to the missing parameters in the force ﬁeld, we do not expect to see a complete
interconversion of the loop between the two forms. However, a motion of
the loop clearly happens. The trajectory snapshot shows that the loop is
starting a closure motion (going from the active to inactive conformation).
This approach is really promising. Using the correct force ﬁeld this move
should lead to an accurate sampling of the phase space and give insight on
the closure mechanism.CHAPTER 5. SOFTWARE DEVELOPMENT 80
5.4 Miscellaneous
The ProtoMS51 software although very fast and eﬃcient is not perfect. Draw-
backs are
• it does not incorporate any analytical tools
• its core structure is written in F77 limiting the use of memory
• a limited number of ﬁles can be opened at the same time
The last two points make running long simulation from one input ﬁle
impossible (each time a pdb ﬁle is written or a restart is closed/open, it
stays in the stack pile, and the maximum number of ﬁles F77 can handle is
limited to 30). To overcome the problem, MC simulations using ProtoMS51
are run in block. Each block can be described from the following process:
• Load force ﬁelds, simulation parameters and proteins, solvents, solutes
• Load conformational information
• Run N steps of simulation
• Write new conformational information
So each block can be repeated, reading conformational information from the
previous. To perform this task, the use of Perl scripts has come in very
handy. A Perl script has been written to write the input ﬁle and then run
the simulation. The script can display block numbers in two diﬀerent ways,
using standard increments from 1 to N, or using a Cshell incrementation
from 001 to NNN.
The ProtoMS51 package allows the user to write PBD structure of the
system every N steps. So conformational analysis can be made using the
PBD output.
Once again, the use of the Perl language has proved to be an eﬃcient
tool.
Several script have been coded to perform several type of analysis:
• script to compute the radius of gyration of a protein for the whole
simulationCHAPTER 5. SOFTWARE DEVELOPMENT 81
• script to compute the Ramachandran plot of a protein for the whole
simulation (minus N and C terminal residues)
• script to build a water shell around a given number of residues or solutes
• scripts to compute small task such as reordering outputs, normalising
angled between 0 and 2π, compute distribution of angles from a set of
data, repeating commands, computing standard and ﬂoating average
etc etc.
Parallel tempering simulations aim to improve sampling of the phase
space, by exchanging replicas at diﬀerent temperatures (see section 3.6). The
ProtoMS51 package does not feature such an implementation. However, as
the temperature of the simulation can be user-deﬁned for a given simulation,
a parallel tempering script has been written.
The script runs several simulations at diﬀerent temperatures and every
X steps, performs an exchange test based on the energy of the system. If the
test is successful, the restart coordinates are exchanged and the next block of
the simulations is run. At the end of the simulation the output ﬁle is used to
calculate the acceptance rate and another Perl script to draw the exchange
plot.
5.5 Concluding remarks
A variety of ways to use standard or enhanced CRA is now available in
the ProtoMS51 package to allow greater sampling of protein backbone. We
have been interested in using the CRA algorithm to compute free energies
and study loop ﬂexibility rather than study folding of proteins. The next
chapters will describe the use of the CRA to solve biological problems in
several systems.Chapter 6
Lysozyme
Lysozyme was discovered by Alexander Fleming in 1922, during his search
for medical antibiotics111. Like most great discoveries, luck played its part.
During a cold, Fleming had a drop of mucus fall into a bacterial culture
and discovered that the bacteria were killed. This phenomenon led to the
discovery of lysozyme, which had killed the bacteria. Sadly, owing to its size,
Lysozyme could not be used as a drug (but later Fleming discovered the ﬁrst
anti-biotic penicillin, once again a share of talent and luck).
Lysozyme serves as a non-speciﬁc innate opsonin∗ by binding to the bac-
terial surface, reducing the negative charge and facilitating phagocytosis of
the bacterium before opsonins from the acquired immune system arrive at
the scene.
The mechanism113 responsible for reducing the negative charge, involves
hydrolysis of the β (1-4) glycosidic bond between N-acetylglucosamine sugar
(NAG) and N-acetylmuramic acid sugar (NAM) (see ﬁgure 6.1). This reaction
takes place in a long deep cleft, which contains the active site of Lysozyme
(residues Glu35 and Asp52 for chicken egg white Lysozyme).
The ﬁrst crystal structure of Lysozyme was obtained in 1974 by Diamond
with a resolution of 2 ˚ A114 and can be found in the PBD database under the
∗Opsonins are macromolecules binding to the surface of a cell and aiming to enhance
the phagocytosisCHAPTER 6. LYSOZYME 83
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Figure 6.1: Representation of the target site of the lysozyme112
references 1lyz to 6lyz. There are more than 1400 hits on the PBD database
for the keyword Lysozyme. The L99A mutant is known to make enough space
in the cavity to accommodate a benzene ring in the binding pocket115,116. This
mutant has been use for protein engineering and such binding inhibits the
function of the protein115,116.
In this chapter we will ﬁrst review previous work on the T4 lysozyme
L99A mutant and give some insight into the crystal structures (rcsb database
references 181L to 188L117,118). Then we will detail and discuss the work
achieve by using the CRA algorithm to sample the lysozyme phase space.
6.1 Previous work and structure
6.1.1 Protein structure
The L99A mutant of the T4 lysozyme, has been crystallised bound to several
ligands117,118. Entries for each ligand are:
• benzene 181l
• benzofuran 182l
• indene 183l
• isobutylbenzene 184lCHAPTER 6. LYSOZYME 84
• indole 185l
• n-butylbenzene 186l
• para-xylene 187l
• ortho-xylene 188l
Figure 6.2 shows a superposition of some crystal structures described in
the references117,118.
Figure 6.2: superposition of the crystal structure of the lysozyme bound to
diﬀerent ligands117,118. F-loop is represented in the shaded region. Colour
code: 181L in blue, 182L in red, 183L in cyan, 184l in green, 185l in grey and
186L in magenta.
Each crystal structure is bound to a diﬀerent ligand and the F-loop of
the protein adopts a diﬀerent conformation. The RMSD between the diﬀerent
structures can be found in table 6.1.
Table 6.1 shows that most of the deviation occurs in the F-loop region.
Although the RMSD between the various structures is small, the F-loopCHAPTER 6. LYSOZYME 85
PDB
code
182l 183l 184l 185l 186l 187l 188l
protein 0.314 0.377 0.389 0.422 0.296 0.233 0.363
F-loop 0.586 1.034 1.233 0.534 0.701 0.593 1.095
Table 6.1: RMSD between the lysozyme bound to benzene and the lysozyme
bound to other ligands (values in ˚ A). Second row shows the RMSD with
respect to the complete crystal structure, third row, the RMSD of the F-
loop only, both RMSDs computed with all the heavy atoms of the loop.
RMSD have been calculated after superposition of the backbone of the crystal
structures.
adopts quite diﬀerent conformations for each ligand (see ﬁgure 6.2 for a
more graphical view). The next section will describe a brief overview of the
existing work executed on the lysozyme protein.
6.1.2 Existing work
Both experimental and theoretical studies have been performed on the T4
lysozyme L99A mutant25,117–126 to obtain binding free energies for the set
of ligands. In silico results were obtained using MD and several techniques
to enhance the sampling. Some methods used restraints on the ligands25,125
or another method called conﬁne and release119,120 to overcome some inter-
nal energetic barriers. The experimental binding free energies were obtained
using the protocol described in the references117,118.
Details of the simulations can be found in the respective publications25,119,120.
To summarise the methods, Roux et al uses restrains on the ligands. The lig-
and in the bulk is restraints to the position it adopts in the bound state
and is then translated into the binding site where it is released completely.
The method developed by Soichet et al deals with the high energy barrier of
the rotational changes of the side chain of the valine 111 by using a conﬁne
and release method. The Binding free energy is computed by ﬁrst driving
the protein to its bound conformation. The ligand is inserted in the binding
pocket while the protein is kept conﬁned. To close the cycle, the bound sys-
tem is released from any constraints. Such method is used to overcome theCHAPTER 6. LYSOZYME 86
Experimental
value
MD value119 MD value25
benzene -5.19±0.16 -4.56±0.20 -5.96±0.19
benzofuran -5.46±0.03 -3.53±0.06 -5.62±0.20
indene -5.13±0.01 -1.75±0.07 -2.47±0.24
isobutylbenzene -6.51±0.06 -5.01±0.20 -9.67±0.38
indole -4.98±0.06 -0.42±0.08 -4.24±0.17
n-butylbenzene -6.70±0.02 -4.87±0.14 -8.75±0.36
p-xylene -4.60±0.06 -1.27±0.18 -9.06±0.21
o-xylene -4.67±0.06 -3.54±0.17 -7.59±0.19
Table 6.2: ∆G◦
binding in kcal/mol for various ligands from previous studies.
kinetic trapping of the metastable state created by the side chain. Results in
table 6.2 shows that theoretical studies do not reproduce systematically the
experimental binding free energies. There are several issues to be dealt with.
The ﬁrst issue is the conformational change in the F-loop of the lysozyme.
The binding pocket of the lysozyme is big enough to accommodate a benzene
ring plus a small ”blob”. However the binding pocket is very tight, and the
F-loop has to accommodate for changes in the conformation of the ligand.
Owing the nature of the shape of the ligand, MD might not be able to sample
the system for ”long enough”. Work from Roux25 seems to suggest that the
length of a typical MD run is not enough to sample such changes which in-
dicates that the amplitude of the sampling could not be achieved using time
related methods. The second issue is the presence of a rotamer on the valine
111 (see ﬁgure 6.3). Two diﬀerent rotamers of the valine 111 exist in diﬀerent
crystal structures to accommodate diﬀerent ligands. These rotamers create
repulsive/attractive interactions with the ligand, making the sampling of the
binding energy more diﬃcult.
The conformational change from one rotamer to the other cannot be
sampled using the standard MD method due to the high energetic barrier.
To over come this barrier, speciﬁc methods have to be used119,120. But evenCHAPTER 6. LYSOZYME 87
Figure 6.3: Two rotamers of the valine 111 in the PDB references 184l (blue)
and 185l (red).
using such methods, the calculated relative binding free energies are diﬀerent
from the experimental ones.
Prior studies using MC methods have been performed within our group
to try to reproduce the experimental relative binding free energy between the
indole and the isobutylbenzene ligands. To compute relative binding aﬃnities
between two ligands, two routes are possibles (see ﬁgure 6.4). The binding
free energies for both ligands are computed and then the diﬀerence between
the energies is made (route ∆G4 − ∆G2 in ﬁgure 6.4), or the alchemical
transformation56 route is used. One ligand is mutated into another in both
the protein and solvent environment, and the diﬀerence of the energies is
made (route ∆G1 − ∆G3 in ﬁgure 6.4).
We have been using the alchemical transformation route56. For both the
184l and 185l crystal structures, the ligand has been perturbed from indole
to isobutylbenzene and the relative binding free energy computed. Several
simulation were performed using diﬀerent solvent models and a scoop of the
protein:
• using an explicit water cap and no backbone moves on the scoop.CHAPTER 6. LYSOZYME 88
Figure 6.4: Thermodynamical cycle used for the MC simulations.
• using an explicit water cap and backbone moves on the F-loop of the
scoop.
• using an explicit water cap and backbone moves on the whole scoop.
• using GBSA and no backbone moves on the scoop.
• using GBSA and backbone moves on the F-loop of the scoop.
• using GBSA and backbone moves on the whole scoop.
Backbone moves are rigid unit backbone moves as deﬁned in section 3.3.1.
Each of these simulations have been performed at 25 ◦C using NVT dual
topology57,58 and the Amber and GAFF forceﬁeld39,40. The simulations us-
ing the water cap were run in blocks of 10K MC steps. First 100 blocks of
equilibration were run, and then 500 blocks for data collection. RETI57,58
moves were performed every 2 blocks (20K steps). GBSA simulations follow
the same protocol only with a 20 ˚ A cut oﬀ, a threshold of 0.005 ˚ A for the
update of the GBSA shell, and blocks of 3×1000 MC steps. Results are dis-
played table 6.3. Values of the relative binding free energy are in kcal/mol.
The ﬁrst column tells the nature of the solvent, second column the nature
of the backbone moves, none (oﬀ), everywhere (on) or only on the F-loop
(Helix-F).CHAPTER 6. LYSOZYME 89
Backbone moves Starting from 184l Starting from 185l
Water
cap
None -7.45±0.17 6.16±0.22
On -3.44±0.26 2.08±0.38
Helix-F -7.16±0.20 3.67±0.22
GBSA
None -4.80±0.35 8.34±0.32
On -2.41±0.29 0.97±0.44
Helix-F -4.73±0.24 5.81±0.40
Table 6.3: relative binding free energy between the indole and the isobutyl-
benzene in the 185L crystal structures(courtesy of Dr Michel)
Table 6.3 shows that standard MC simulations do not reproduce exper-
imental results. There are several diﬃculties associated with the mutation
from indole to isobutylbenzene:
• the two ligands have a completely diﬀerent shape
• experimental relative binding aﬃnity is less than 2 kcal/mol. Com-
puting relative binding free energies for such small diﬀerence within 1
kcal/mol is acceptable, however ideally we would like to look at a set
of data in which the diﬀerence in aﬃnity is more signiﬁcant.
• the valine 111 presents diﬀerent rotamers in the two crystal structures.
However the use of backbone moves is a clue that the conformation of the
F-loop is critical in the binding process. The hypothesis was made that the
use of large scale moves such as the CRA will beneﬁt the sampling and the
calculation of the relative binding aﬃnity.
The next section will discuss the eﬀect of using MC simulations and the
CRA algorithm in the sampling of the F-Loop and the inﬂuence in the cal-
culation of the relative binding aﬃnity.CHAPTER 6. LYSOZYME 90
6.2 Use of CRA in the lysozyme study
The conformational changes happening on the F-loop of the lysozyme protein
have proved to be an interesting challenge for the standard sampling methods.
In this section we will discuss the eﬀect of the CRA algorithm on the sampling
of the loop and the computation of the relative binding free energies.
6.2.1 Conformational change
Owing our prior knowledge of lysozyme, several simulations have been run
on the crystal structures bound to the isobutylbenzene (PDB ﬁle 184l) and
the indole (PDB ﬁle 185l). For all the simulations, unless stated otherwise,
solvent was modelled using an implicit model (GBSA see section 3.6), cut oﬀ
for electrostatic interactions was set to 10 ˚ A, the cut oﬀ for the GBSA to 20 ˚ A,
the threshold for the re-computation of the GBSA was set to 0.005 ˚ A, a scoop
of 15 ˚ A around the biggest ligand was used (see ﬁgure 6.5), CRA moves were
used with a prerotation length of 4 segments (as described by Ulmschneider
et al83). The coordinates of the following residues were constrained: 3, 5-7,
10-11, 22, 70-73, 76, 80, 92-94, 123-128, 135, 137, 139-143, 145, 147-148, 151-
152, 154-156, 158-159, 161. These residues are located outside a 10 ˚ A radius
of the ligand.
The scoop of the protein had an initial charge of +5. The charge was
reduced to zero by neutralising three lysine residues lying in the outer part
of the scoop K124,K135,K147. Afterwards, two extra residues were added to
the scoop, Asp159 and Glu5.
First the inﬂuence of various parameters have been tested. Parameters
such as having rigid unit backbone moves outside the F-loop, the length of
loop on which the CRA moves were applied as well as the inﬂuence of keeping
some of the residues ﬁxed. Owing to its concerted nature (both ends to be
kept ﬁxed), the CRA move has been applied outside the F-loop (residues
106-115) from residues 105 to 118.
To enhance the sampling, ligands have been swapped over. By having
the ligands crossed from one crystal structure to another, we were expectingCHAPTER 6. LYSOZYME 91
Figure 6.5: Scoop of the 184l protein used in the simulations over the original
crystal structure (red ribbon). The backbone atoms of the complete protein
and the isobutylbenzene (green) are also represented.
to see the conformation of the F-loop change towards the corresponding
conﬁguration of the F-loop. A ﬁrst set of ﬁve simulations has been run,
changing several parameters. All simulations have been run for 2 million
steps.
• First simulation where no rigid unit backbone moves were allowed on
any residues, residues mentioned above were kept ﬁxed (no side chain
moves, no backbone moves) and CRA moves performed between the
residues 105 and 118;
• second simulation where rigid unit backbone moves were allowed on
residues inside a 10 ˚ A radius, residues mentioned above were kept ﬁxed
and CRA moves performed between the residues 105 and 118;
• third simulation where rigid unit backbone moves were allowed on
residues inside a 10 ˚ A radius, no residues were kept ﬁxed and CRACHAPTER 6. LYSOZYME 92
moves performed between the residues 105 and 118;
• fourth simulation where rigid unit backbone moves were allowed on
residues inside a 10 ˚ A radius, no residues were kept ﬁxed and CRA
moves performed between the residues 101 and 122;
• ﬁfth simulation where no rigid unit backbone moves were allowed on
residues inside a 10 ˚ A radius, residues mentioned above were kept ﬁxed
and CRA moves performed between the residues 101 and 122.
The RMSD of the residues 105 to 118 along the simulation with respect
to the 184l crystal structure during the simulation are plotted ﬁgure 6.6. The
eﬀect on the sampling to the diﬀerent parameters is discussed according to
the observation on the RMSD from ﬁgure 6.6.
Figure 6.6: RMSD of the trajectories of the ﬁve simulations with respect
to the 184l crystal structure. Simulations 1 to 5 are respectively black, red,
green, blue and violet.
The length of the loop on which CRA was applied seems to have an im-
portant eﬀect on the sampling (violet curve against black curve in ﬁgure 6.6).CHAPTER 6. LYSOZYME 93
Allowing rigid unit backbone moves on the other parts of the protein (green
curve) enhances the sampling of the F-loop too by allowing the other parts
of the protein to relax in order to accommodate the change of geometry of
the F-loop (the green curve achieves greater sampling than the black and red
ones). Allowing all residues to move increases the sampling (blue curve in ﬁg-
ure 6.6), but due to the nature of the system (scoop of the protein) and the
type of moves (see section 3.3.1) such a protocol is not recommended. Moving
the outer ring of the scoop is not recommended as the residues composing it
would just drift away, leading to an incorrect structure of the protein.
So the optimised sampling is achieved when rigid unit backbone moves
are allowed outside the F-loop and CRA moves performed on a slightly longer
segment of the protein (violet curve in ﬁgure 6.6). This protocol aimed to
achieve the best sampling of the F-loop will be later used in the free energy
perturbation (see section 6.2.3).
Others sets of simulations were run, with the appropriate ligand and no
ligand respectively, for both crystal structures. A second set of simulations
has been run on both crystal structures without ligand. This set is made up
of 4 simulations:
• ﬁrst simulation where rigid unit backbone moves were allowed, but
CRA moves performed between the residues 101 and 123 at 25◦C;
• second simulation where rigid unit backbone moves were allowed and
CRA moves performed between the residues 101 and 123 at 100◦C;
• third simulation where rigid unit backbone moves were allowed and
CRA moves performed between the residues 101 and 123 at 150◦C;
• fourth simulation where rigid unit backbone moves were allowed and
CRA moves performed between the residues 101 and 123 at 200◦C.
The third set of simulations has been performed on both crystal structures
including their respective ligand. This set is made of 4 simulations:
• ﬁrst simulation where no rigid unit backbone moves were allowed, but
CRA moves performed between the residues 101 and 123 at 25◦C;CHAPTER 6. LYSOZYME 94
• second simulation where rigid unit backbone moves were allowed and
CRA moves performed between the residues 101 and 123 at 100◦C;
• third simulation where rigid unit backbone moves were allowed and
CRA moves performed between the residues 101 and 123 at 150◦C;
• fourth simulation where rigid unit backbone moves were allowed and
CRA moves performed between the residues 101 and 123 at 200◦C.
The last two sets of simulations have conﬁrmed the results of the ﬁrst
set as to which parameters to use in terms of sampling. In the third set, no
major changes in the conformation of the F-loop were observed from respect
to the crystal structures (as expected) but rather a nice sampling around the
starting structure.
Another set of longer simulations was run for the crossed ligands using
the CRA between the residues 105 to 118 and allowing rigid unit backbone
moves on the whole scoop of the protein. The RMSDs of both trajectories
with respect of both the 184l and 185l crystal structure have been plotted
ﬁgure 6.7 and 6.8 respectively.
When the indole is used in the 184l crystal structure (crossed ligands),
the RMSD shows that the F-loop does not converge toward the conforma-
tion of the 185l crystal structure. The black and red curve should cross each
other. The average value of the black curve should go to near zero and the
average value of the red one should converge around 1.5 ˚ A. Observing such
behaviour would mean that the F-loop has adopted the conformation rele-
vant to the ligand in the binding pocket. However, converging structures are
obtained until 5 million MC steps where the F-loop starts to evolve freely
(no more convergence of the RMSD toward a deﬁnite structure). This could
simply be explained by the fact that the indole occupies a smaller volume
than the isobutylbenzene and the fact that the binding pocket of the 184l
crystal structure is bigger than the binding pocket of the 185l crystal struc-
ture. Snapshots of the simulations conﬁrm this hypothesis, and shows a good
sampling of the indole within the binding pocket. The value of the dihedral
angle deﬁned in ﬁgure 6.10(a) is plotted in green ﬁgure 6.7 and aims to quan-
tify the sampling of the ligand within the binding pocket (see also ﬁgure 6.9CHAPTER 6. LYSOZYME 95
Figure 6.7: RMSD of the simulation starting with the 184l crystal structure
bound to indole. RMSD is computed with respect to the 184l (black) and
185l (red) crystal structure. The RMSD is calculated on the backbone atoms
only. Green curve is the value of the angle deﬁned in ﬁgure 6.10(a).
for a superposition of two structures of the indole during the simulation).
The value of the angle deﬁned in ﬁgure 6.10(a) shows that the indole sam-
ples much of the binding pocket during the simulation. The sudden change
in the value at around 4 million and 8 million MC steps is due to the ligand
drifting away from its original conformation in the binding pocket.
When the binding pocket of 185l crystal structure is ﬁlled with the isobutyl-
benzene, the results are however not up to expectations. Having the isobutyl-
benzene in the indole binding pocket, repulsive interactions were expected to
lead to the F-loop quickly adopting a conformation close to the 184l crystal
structure. The RMSD of the F-loop (ﬁgure 6.8) shows this is not the case.
However, expecting to capture the subtle change between the two confor-
mations of the F-loop by using only RMSD is a bit optimistic. As the CRA
algorithm drives changes in bond and dihedral angles, using a RamachandranCHAPTER 6. LYSOZYME 96
Figure 6.8: RMSD of the simulation starting with the 185l crystal structure
bound to isobutylbenzene with respect to the 185l (black) and 184l (red)
crystal structure. The RMSD is calculated on the backbone atoms only.
plot26 should provide good insights of the conformational changes. For three
crystal structures (apoprotein (1l92), 184l, 185l), the Ramachandran plot26
has been plotted in ﬁgure 6.11.
The colour code of the ﬁgure 6.11 is: black residue 102, red residue 103,
green residue 104, blue residue 105, dark green residue 106, brown residue 107,
maroon residue 108, violet residue 109, cyan residue 110, magenta residue
111, orange residue 112 and indigo residue 113. The Ramachandran plot26,
shows that except for 3 residues, the conformation of the dihedral angles
of the loop are very similar for the three structures. Residues that have
relatively diﬀerent Φ,Ψ conformations are residues 108, 110, and 111, but
the value of the angles Φ and Ψ are still within a space of twenty degrees.
The average value of the Φ and Ψ angles with the standard deviation during
both crossed simulations (184l crystal structure with indole and 185l with
isobutylbenzene) are plotted in ﬁgure 6.12.CHAPTER 6. LYSOZYME 97
Figure 6.9: Superposition of to structures of the indole in the crystallographic
binding pocket after 2 and 7 million of MC steps (respectively blue and red).
An interesting feature to note from the ﬁgure 6.12, is that during both
crossed simulations, the F-loop samples regions of the conformational space
that are very close to each other. For both simulations, the sampling of the
backbone is very similar. The spread of the Φ and Ψ angles for the 184l crys-
tal structure with indole overlap the spread of the Φ and Ψ angles for the
185l crystal structure with the isobutylbenzene. The plot for the simulation
using the 184l crystal structure shows that the residue 106 achieves a greater
sampling than its counterpart in the 185l crystal structure. However, both
residues are sampling the same region of the phase space. Thus the distribu-
tion of the Φ and Ψ angles cannot give any insight into the phenomenon that
occurs when the isobutylbenzene is inserted in the binding pocket of the 184l
crystal structure (limited sampling). The explanation of such phenomenon is
hence, unlikely to be backbone related.
In ﬁgure 6.3 the two valines are shown to have diﬀerent rotamers. This is
of critical importance in describing the behaviour of the F-loop of the 185l
crystal structure when bound to isobutylbenzene.
The next section will discuss the issues related to the existence of the twoCHAPTER 6. LYSOZYME 98
(a) Atoms used to deﬁne the dihe-
dral angle between the indole (white
spheres) and the Cα of residues 10
and 11 (blue spheres).
(b) Atoms used to deﬁne the dis-
tances between the valine 111 and
the isobutylbenzene (spheres). On
the valine the atom CG1, CG2, CB
are respectively red, grey, green.
One the isobutylbenzene the atom
C10 is cyan.
Figure 6.10: Atom used in the simulations to compute angles and distances.
Simulation of the 184l crystal structure with indole (sub-ﬁgure 6.10(a))
and simulation of the 185l crystal structure with the isobutylbenzene(sub-
ﬁgure 6.10(b)).
rotamers and the implications of such a change in the side chain conformation
on the sampling of the F-loop.
6.2.2 Rotamer dependency
Simulations using the isobutylbenzene in the 184l crystal structure binding
pocket have not led to the expected results. Both the RMSD and the Ra-
machandran plot26 of the F-loop have failed to prove signiﬁcant sampling
of the F-loop towards the 184l crystal structure. Careful observation of the
snapshot of the simulation, shows that the sampling of the F-loop is linked
to the sampling of the isobutylbenzene. This suggests the presence of new in-
teractions between the isobutylbenzene and the F-loop. The behaviour of theCHAPTER 6. LYSOZYME 99
Figure 6.11: Ramachandran plot of the apoprotein (circles), 184l (+) and
185l (x) crystal structures.
isobutylbenzene and the valine 111 have been investigated during the simula-
tion and interesting features have been discovered. It appears that after a very
short period of time (500 000 MC steps), the distance between the isobutyl-
benzene and the valine 111 remains constant. The ﬁgure 6.10(b) shows the
atoms used to compute some speciﬁc distances between the isobutylbenzene
and the valine 111.
The distance between the atom C10 of the isobutylbenzene with the atoms
CB, CG1, CG2 of the valine 111 are plotted ﬁgure 6.13 respectively in green,
red and black.
The ﬁgure 6.13 clearly shows that the position of the isobutylbenzene and
the valine 111 are linked. The three distances quickly become trapped into a
local energy minima. The distances plotted ﬁgure 6.13 suggest the existence
of a hydrophobic cluster between the side chain of the valine 111 and the
methyl group of the tail of the isobutylbenzene. The two methyl group are
facing one to the other and the hydrogens have a staggered position whenCHAPTER 6. LYSOZYME 100
Figure 6.12: Ramachandran plot for the 184l with indole (plain) and 185l with
isobutylbenzene (dashed). The average of the angles during the simulation is
represented centred on the standard deviation.
looked through the atom C10 of the isobutylbenzene and the atom CG1
of the valine 111. So whereas some repulsive interactions were expected,
the diﬀerent position of the side chain of the valine 111 creates favourable
interactions. Whereas such interactions are weak, they are nevertheless strong
enough to restrain the position of the F-loop close to the isobutylbenzene.
The interaction between the two methyl group is strengthened by the tight
ﬁt of the binding pocket. The aromatic part of the isobutylbenzene is tightly
bound to the binding pocket and hence little space is accessible for the ligand
to move.
To conﬁrm this hypothesis, the same simulation has been run at 523 K
(25◦C). The values of the angle χ of the valine 111 for both simulations (298
and 523 K) are plotted ﬁgure 6.13. The data at 523 K clearly show a change
in the value of the dihedral angle χ between the value 180◦ and 300◦ (-60◦).
These two values correspond to the two diﬀerent rotamers of the valine. ThisCHAPTER 6. LYSOZYME 101
Figure 6.13: Distances between the atom C10 of the isobutylbenzene and the
atom CB (green curve), CG1 (red curve), CG2(black curve), and dihedral χ
of the valine 111 at 298 K (blue curve) and 523 K (violet curve).
phenomenon conﬁrms our hypothesis of a hydrophobic cluster. At 523 K,
the energetic barrier of the rotamer position is easily overcome, allowing the
valine to adopt the appropriate rotamer. The change in conformation (in
purple in ﬁgure 6.13) appears after only 1.5 million MC steps.
To try to enhance the sampling, PT59,60 techniques have been used. For
both crystal structures, ligands have been swapped and a set of 14 parallel
simulation starting from the same conﬁguration at diﬀerent temperatures
have been run. Temperatures were spread between 298 K and 473 K as fol-
low: 298, 303, 310, 315, 323, 333, 345, 358, 373, 393, 408, 423, 443, 473.
Every 10000 MC steps, the exchange test is performed according to the equa-
tion 3.41. The path of the simulations starting with the 185l crystal structure
and the isobutylbenzene at 298 K (25◦C), 323 K (50◦C), 373 K (100◦C), 423
K (150◦C) and 473 K (200◦C) are represented in ﬁgure 6.14.
Figure 6.14 shows that all of the ﬁve simulation are exchanged along theCHAPTER 6. LYSOZYME 102
Figure 6.14: Path for the simulations starting with the 185l crystal structure
and the isobutylbenzene at 25◦C (Black), 50◦C (red), 100◦C (green), 150◦C
(blue) 200◦C (brown)
temperature gradient allowing greater sampling of the phase space. Simu-
lations at the extreme range of temperatures manage to travel across the
whole range of temperatures. Such sampling enables the system at 298 K to
exchange conﬁguration with higher temperature as expected. To see if the
use of the PT59,60 has an eﬀect on the sampling of the dihedral χ of the valine
111, the value of the dihedral at 298 K has been plotted in ﬁgure 6.15.
The value of the angle χ of the valine 111 oscillates between the value of
the two rotamer after 3 millions MC steps. Careful examination of ﬁgure 6.14
shows that the change in the dihedral occurs when the conﬁgurations gen-
erated at 473 K are exchanged with the conﬁguration generated at 298 K.
So the rotamer problem can be overcome by the use of a PT59,60 simulation.
Figure 6.15 shows that both rotamers are present at 25◦C. Only the appro-
priate rotamer for the ligand was expected at 25◦C. This is related to someCHAPTER 6. LYSOZYME 103
Figure 6.15: Value of the angle χ of the valine 111 in degrees for the sim-
ulations starting with the 185l crystal structure and the isobutylbenzene at
25◦C.
issues with the forceﬁeld, that failed ∗ to capture all the changes in the valine
conformation.
The next section will focus on computing the relative binding free en-
ergy between the two ligands and how the rotamer issue has been addressed
during such computations (using for example the results of the PT59,60 sim-
ulations). The relative binding free energy for the whole sets of ligand will
be investigated as well.
∗The term failed however might not be correct from a semantic point of view. The two
diﬀerent conformations appears to be have the same weight. The force ﬁeld sees each of
them as being statistically relevant and do not sample one preferably over the other.CHAPTER 6. LYSOZYME 104
6.2.3 Free Energy perturbation
Relative binding free energy between indole and isobutylbenzene
To complete previous work on the lysozyme the relative binding free energy
between the isobutylbenzene and the indole have been computed for both
crystal structures:
• Starting from the 184l crystal structure mutating the isobutylbenzene
to the indole.
• Starting from the 184l crystal structure mutating the indole to the
isobutylbenzene.
The RETI57,58 method has been used to compute the relative binding free
energy between the indole and the isobutylbenzene. Before performing the
simulations, the system was equilibrated 50000 MC steps with both ligands
present in the binding pocket and a λ of value 0.5 has been run. The ﬁnal
conﬁguration of the equilibration run was scattered across the twelve values
of λ and used as a starting conﬁguration to compute the relative binding free
energy. Simulations were performed using the optimised protocol for sam-
pling discussed above (ﬁxed residues, rigid unit backbone moves outside the
F-loop and CRA moves used between the residues 101 to 123) and the dual
topology method57,58. 10 RETI57,58 moves each of 150000 steps were per-
formed. Each simulations has been repeated 3 times. Twelve λ windows were
used to perform the RETI57,58 perturbation: (0, 0.10, 0.20, 0.30, 0.40, 0.50,
0.60, 0.70, 0.80, 0.90, 0.95, 1.00). To be able to compute the relative binding
free energy according to the ﬁgure 6.4, the ligands have been perturbed each
into the other in GBSA. The results of the three runs were averaged and are
displayed in the table 6.4.
Table 6.4 shows that starting from the 184l structure gives a relative
binding energy in good agreement with the experimental values. The rela-
tive binding free energy between the isobutylbenzene and the indole is only
0.8 kcal/mol higher with a standard error of 0.6 kcal/mol. On the other
hand, the perturbation from the indole to the isobutylbenzene starting fromCHAPTER 6. LYSOZYME 105
Starting
structure
Experimental
values
MD
simulations25 MC simulations
using CRA
184l 1.6 5.4±0.3 2.4±0.6
185l -1.6 -5.4±0.3 2.1±0.6
Table 6.4: ∆∆Gbind between the indole and the isobutylbenzene with stan-
dard errors (average of the 3 simulations). Values are in kcal/mol.
the 185l crystal structure, underestimates the relative binding aﬃnity of the
isobutylbenzene by 3.7 kcal/mol.
Literature states that the initial conformation is of critical importance
for the results of the calculations25,119 and the presence of the wrong rotamer
can bias the computational value of the relative binding free energy by up
to 4 kcal/mol119. Most important is that valine 111 plays a key role in the
sampling of the F-loop. This hypothesis and the hydrophobic cluster discov-
ered during the previous simulation would explain the over-estimation of the
relative binding free energy.
Side-chain moves were modiﬁed so that the dihedral angle χ of the valine
111 was allowed to move freely between −π and π and this speciﬁc move was
apply to the RETI simulations (both sets) starting from the original crystal
structure to try to reproduce experimental results and observe a change in
the conformation of the side chain of the valine 111. However results were
non conclusive. The valine 111 retained its original conformation and the
relative binding free energies obtained are still within the range of standard
errors from the previous simulations.
To see if more accurate results could be achieved, both set simulations
were re-run, using the appropriate rotamer of the valine 111 with respect to
the ﬁnal ligand and the same protocol as before. The angle χ of the valine 111
was manually changed to the expected value and the remainder of the protein
was unchanged. The relative binding free energy from the isobutylbenzene
to the indole has been reduced so that the experimental value of the relative
binding energy is only 0.2 kcal/mol lower to the computed value. Changing
manually the rotamer of valine 111 on the 185l to accommodate the isobutyl-CHAPTER 6. LYSOZYME 106
benzene has proved to be even more successful25. The relative binding free
energy of the mutation indole to isobutylbenzene has been reduced from 2.1
kcal/mol to -1.0 kcal/mol (see table 6.5).
Experimental
results
MC/CRA MC/CRA
on the
rotamers
MC/CRA
PT
184l 1.6 2.4±0.6 1.8±0.6 -
185l -1.6 2.1±0.6 -1.0±0.6 -2.9±0.7
Table 6.5: ∆∆Gbind between the indole and the isobutylbenzene with stan-
dard errors (average of the 3 simulations). Values are in kcal/mol.
In the previous section we have investigated the eﬀect of using the PT59,60
method on the side chain of the valine 111. The PT59,60 have been proved to
enable the rotation of the valine 111 side chain to the appropriate position.
Twelve conﬁgurations of the system at 298 K were chosen from the PT59,60
simulation and used as starting conﬁgurations for the RETI57,58 simulation
using the 185l crystal structure to see if the conﬁgurations from the PT run
could overcome the rotamer issue. The use of conﬁgurations drawn from the
PT59,60 simulations lead to a decrease of the relative binding free energy
from 2.1 to -2.9 kcal/mol (with a standard error of 0.7 kcal/mol). The rela-
tive binding free energy is still overestimated by around 1 kcal/mol in favour
of the isobutylbenzene but the ranking order is in agreement with the exper-
iment (isobutylbenzene is more likely to bind than indole). Relative binding
free energies obtained using diﬀerent rotamers or simulations techniques to
enhance the rotamer sampling are summarised table 6.5. Figure 6.16 shows
the value of the dihedral χ of valine 111 for the simulations where the indole
is mutated into the isobutylbenzene for λ equal to one.
Figure 6.16 shows that whereas values using the minimised crystal struc-
ture do not sample the change in the dihedral (average value of χ is 180
degree), the use of random conﬁgurations drawn from the PT59,60 simula-
tions ables the system to jump over the rotational energy barrier, allowing
the dihedral to sample more conﬁgurations using its appropriate value (300CHAPTER 6. LYSOZYME 107
Figure 6.16: Value of the angle χ of the valine 111 in degrees for the simula-
tions starting with the 185l crystal structure (indole mutated into isobutyl-
benzene) for λ = 1. Simulations using random conﬁgurations drawn from
the PT59,60 run are in black. Simulations starting with a minimised crystal
structure are in red.
degree). The value of 180 degree is not sampled when the conﬁgurations
drawn from the PT are used. This suggest either a problem with the crystal
structure (as a methyl group is only nine electrons) or with the forceﬁeld.
Relative binding free between benzene and the whole set of ligands.
The relative binding free energy between the benzene and the whole set of
ligands used in the literature25,119 has been computed to see if the results of
the indole to isobutylbenzene simulation could be reproduced. A 15 ˚ A scoop
centred on the isobutylbenzene of the 181L crystal structure was used (same
scoop as in the previous section with the same simulation protocols) for all
the simulations. A ﬁrst batch of 50 RETI moves was run, extended to 150
RETI moves. Relative binding free energies over the three simulations haveCHAPTER 6. LYSOZYME 108
been averaged and results can be found in table 6.6.
181L 184l 185l ∆∆Gbind
exp
RETI moves 50 150 50 50
Benzofuran -3.3±0.5 -3.3±0.3 -4.7±0.4 -4.4±0.4 -0.3±0.0
Indene 0.272±0.5 0.4±0.3 -2.4±0.4 -1.5±0.4 -0.1±0.0
Isobutylbenzene 6.0±0.7 5.9±0.4 0.5±0.6 4.0±0.7 -1.3±0.0
Indole -4.8±0.5 -5.1±0.3 -7.1±0.4 -6.1±0.5 0.3±0.0
n-butylbenzene 11.7±0.8 10.7±0.5 7.0±0.9 10.8±0.8 -1.5±0.0
o-xylene N.A. 2.3±0.3 -0.3±0.4 0.8±0.5 0.5±0.0
p-xylene N.A. 2.5±0.3 -0.3±0.6 1.9±0.5 0.5±0.0
Table 6.6: Relative binding free energy between the benzene and a set of lig-
ands, with standard errors. First row display the PDB name of the structure
used for the perturbation. Each RETI move is composed of 30000 MC steps.
Energy is in kcal/mol.
The computed relative binding free energies do not reproduce the exper-
imental results. This is probably due to the diﬀerence in the shape of the
ligands. Starting from the 181L crystal structure, the F-loop has to undergo
major changes in its conformation to adapt to the ligand as the binding
pocket for the benzene is the smallest. Then the simulations were run using
other starting crystal structures (184l and 185l) with larger cavities.
However, these simulations stressed the fact that the initial structure of
the protein seems to be of a critical importance in the computation. The
results of the calculated relative binding free energies are very sensitive to
the initial structure and can be changed by up to 4.7 kcal/mol in the extreme
case of the n-butylbenzene, depending on the shape of the starting structure
and the rotamer of valine 111.
The use of the 184l crystal structure always lowers the relative binding free
energy between the benzene and the other ligands. One probable explanation
for such phenomena is the presence of the rotamer of the valine 111. ThisCHAPTER 6. LYSOZYME 109
has been described in the literature by Soichet et al as a factor of errors up
to 4 kcal/mol in the computed binding free energies120.
Another explanation is the size of the binding pocket. The main reason
being that the larger pocket ables the system to avoid high energy conﬁg-
uration due to repulsive eﬀects. To accommodate the isobutylbenzene, the
binding pocket is bigger than in the 181L crystal structure. So more space
is available for the ligand to sample the cavity, thus increasing the sampling
and leading to better results.
6.3 Concluding remarks
The CRA algorithm has been applied to the lysozyme protein to try to
sample the F-loop. The CRA successfully provides enhanced sampling of the
backbone for the F-loop. The complete interconversion of the F-loop when
ligands are crossed is not observed, although the CRA samples the possible
conﬁguration of the loop with eﬃciency. In the case of the lysozyme, the size
of the binding pocket is not the only parameter to consider. Other parameters
such as the side chain of the valine 111 and the position of the ligand in the
binding pocket have a great eﬀect on the sampling. Methods to enhance the
backbone sampling such as CRA have little eﬀect on the side chains.
The rotamer issue was overcome using the PT59,60 method. By using
PT59,60, high temperature conﬁgurations were brought down to 25 ◦C al-
lowing the appropriate conformation of the valine 111 to be sampled. This
method however is very expensive.
The relative binding free energies between the benzene and the whole
set of ligands were diﬀerent from the experimental values. This raises some
issues. Are the results poor due the non-bonded parameters, or is it only
the case of sampling the valine and the F-loop? As the results are greatly
inﬂuenced by the starting conformation and the rotamer of valine 111, the
issues of the rotamer and the F-loop conformation seem to be the most likely
to inﬂuence the results.
These issues seem to have been solved using the PT59,60, so running the
whole set of ligand with conﬁgurations drawn from the PT59,60 simulationsCHAPTER 6. LYSOZYME 110
would probably give more accurate results, but at a very expensive cost.
The next chapter is going to discuss the eﬀects of using the CRA algorithm
and GBSA solvation in biological systems where loop sampling is of critical
importance.Chapter 7
Biological systems
In this chapter, the use of the CRA algorithm on two diﬀerent biological
systems will be discussed. Proteins such as kinases and phosphodiesterases
which undergo major changes in a conformational loop will be investigated
using the CRA algorithms. Both systems have proved to be a challenge for
standard computational methods.
7.1 Kinases
Kinases are one of the most important classes of enzyme in human physiology
(kinases constitute almost 2% of the human genome) and are critical to
the transmission of signals both within and between cells. They are widely
studied in cancer therapeutics∗.
7.1.1 Kinases, function and conformation
Protein kinases function as components of signal transduction pathways,
playing a central role in diverse biological processes such as control of cell
growth, metabolism, diﬀerentiation and apoptosis. During cancer, many ki-
nases are not able to function properly leading to eternal activation of kinases
∗This chapter does not aim to give a complete overview of kinase structure and func-
tion. The reader is referred to the work of Fabbro for further information127.CHAPTER 7. BIOLOGICAL SYSTEMS 112
such as Bcr-Abl responsible for chronic myelogenous Leukemia. All kinases
share a common fold of around 250 residues known as the kinase core128
that contains the binding pocket and the phosphorilation site. Several crys-
tal structure of the common fold are available in the PDB database (the key
word kinase gives more than 2700 hits). Several drugs exist on the market129
giving insights into the mechanism of inhibition.
Tackling the kinase problem using computational methods has proved to
be diﬃcult due to several key points in the kinase structure. The activation
loop undergoes major displacement during the activation process. A domain
reorganisation then occurs, triggered by the activation of the kinase and then,
the DFG loop (part of the activation loop and involved in the binding of the
ligand) adopts a diﬀerent conformation. The following sections, will describe
the work performed to try to shed light on the mechanisms involved in the
change of both the activation and DFG loops.
Activation loop in the Bcr-Abl Kinase.
Sampling conformational changes in the activation loop of kinases is of major
importance and could illuminate the mechanisms related to the activation or
de-activation of kinases.
Several crystal structures of mutant of the Bcr-Abl kinase exist (PDB
databases 1iep130, 1m52131, 2f4j132, 1opj133, 1fpu134). All the structure are
diﬀerent in geometry and function. The activation loop is present in both
forms (in and out), the DFG loop adopts either of the two known conforma-
tion and the kinases are present in both active and non-active forms. To add
to the problem, mutations such as H396P and T315L (the later referred as
the gate keeper) have been reported. Figure 7.1(a) shows the diﬀerence in
the activation loop between the 1iep and 1m52 crystal structures, and ﬁg-
ure 7.1(b) shows the diﬀerence in the conformation of the DFG loop between
the 1m52 and 2f4j crystal structures.
Sampling the conformational changes of the activation loop or the DFG
loop for the Bcr-Abl kinase using modelling methods should be challenging.
Domain reorganisation presents an even greater challenge due to the am-CHAPTER 7. BIOLOGICAL SYSTEMS 113
(a) Superposition of the 1iep (blue)
and 1m52 (red) crystal structures.
(b) Superposition of the 1m52 (red)
and 2f4j (grey) structures.
Figure 7.1: Representation of the 1iep, 1m52 and 2f4j crystal structures with
activation loop (cartoon representation), DFG loop (CPK representation)
and ligand (licorice representation). Diﬀerence in the DFG between the 1m52
and 2f4j crystal structures is highlighted in grey.
plitude of the change from both a geometrical and temporal point of view.
The Bcr-Abl presenting the T315L or the H396P mutation are known to be
resistant to the action of the Abl inhibitor imatinib (STI-571 or gleevec135)
and understanding the eﬀect of the mutant on the reorganisation process of
the activation loop may lead to better drug design.
Being able to use MC simulations to solve one or several of the issues
raised above would represent a major breakthrough in computational science.
However such a herculean task will requires extensive amount of resources
and more time than one (or maybe several) PhD could provide. To address
the eﬀects of the mutations, one would need to be able to mutate the residues
in the protein whereas investigating the domain reorganisation would need
a coarse grain approach to the problem136–139 due to the time scale and the
number of degrees of freedom changed.
Rather than trying to tackle all the issues related to the kinases, we have
ﬁrst tried to apply the CRA algorithm to some of the kinase conformationalCHAPTER 7. BIOLOGICAL SYSTEMS 114
problems.
7.1.2 Use of CRA on the Bcr-Abl Kinase
Conformational sampling
The CRA algorithm has been used to increase the sampling of MC simu-
lations for the 1iep and 2f4j kinases without ligand at 298 K. Results have
been compared to existing MD simulation performed in-situ in our lab∗. For
both systems, the holo protein has been sampled using MC and MD simu-
lations. By removing the ligands from the binding pocket we expect to see
some changes in the conformation of the activation loop. MD simulations
were run in explicit solvent with TIP3P water molecules61 and the AMBER
forceﬁeld39,40. The simulation was run in 200 blocks of 0.1 ns each with a
time step of 2 fs due to the use of the SHAKE algorithm48 to constrain
the bonds involving hydrogens. The cut-oﬀ for electrostatic interaction was
set to 11 ˚ A and the Particle Mesh Ewald (PME) was use for the long dis-
tance interactions. MC simulations consists in 4500 blocks of 10000 MC steps
using implicit solvent (GBSA) and run in the NVT ensemble. CRA moves
were used between the residues 383 to 409 (activation loop) and the other
residues of the protein were moved using standard ProtoMS51 moves (see
section 3.3.1). One CRA move was performed every 4 moves. Cut oﬀ for
electrostatic interaction was set to 10˚ A.
To compare the eﬃciency of MD and MC methods, one has to rely either
on CPU time or on the sweep method. Owing the diﬀerence in the solvent
modelling (TIP3P61 for the MS simulations and GBSA65,140 for the MC)
the comparing CPU time will not be accurate and hence the sweep method
will be used†. One MC sweep corresponds to the number of MC moves to
statistically move all the residues of a system once, being then equivalent
to one MD time step. To do so, the assumption is made that at each MC
move, a diﬀerent residue is moved. This might not be the case for one sweep,
∗Courtesy of Miss Clapton
†Comparing CPU time also implies the use of similar machines. Southampton Univer-
sity’s local cluster Iridis is made of 12 switches each with diﬀerent types of processor.CHAPTER 7. BIOLOGICAL SYSTEMS 115
(a) Superimposition of the ﬁrst
(red) and last (orange) structure for
the MD simulation.
(b) Superimposition of the ﬁrst
(blue) and last (cyan) structure for
the MC simulation.
Figure 7.2: Superimposition of the ﬁrst and last structures of the simulation
for the 1iep crystal structure without ligand.
but the ergodicity of the system tells us that over the great number of steps
of one simulation this becomes true. However comparing the sweeps is not
as accurate as comparing CPU times, as the size of the sampling has to be
accounted for.
One CRA move changes the coordinates of 5 residues and one standard
ProtoMS51 move changes the coordinates of 2 residues. Owing to the move
probabilities, every 4 MC moves, 11 residues have their coordinates changed.
The proteins have 274 (1iep) and 287 (2f4j) residues. I need to perform 100
MC moves for the 1iep to move all the residues in the protein (104 for the
2f4j). So one MD move corresponds to a sweep of 100 MC moves. If I want
to use the sweeps to compare the sampling achieved with both methods,
I would need to run 100 times 10 million MC step. That represents a one
billion step trajectory. Such a vast number of steps is not achievable using
ProtoMS51, as the code is not build to be parallelised. However, conﬁdent
in the use of the CRA algorithms, we have decided to run one 45 million
step trajectory for each structure ﬁrst and compare the level of sampling ofCHAPTER 7. BIOLOGICAL SYSTEMS 116
(a) Superimposition of the ﬁrst
(red) and last (orange) structure for
the MD simulation.
(b) Superimposition of the ﬁrst
(blue) and last (cyan) structure for
the MC simulation.
Figure 7.3: Superimposition of the ﬁrst and last structures of the simulation
for the 2f4j crystal structure without ligand.
the activation loop. For both structures, initial and ﬁnal structures have been
superimposed, and are displayed ﬁgures 7.2 and 7.3. Once the structures have
been superimposed, the RMSDs of the activation loop between the starting
and the ﬁnal conﬁgurations for both structures have been calculated. Results
are given in table 7.1.
Crystal structure MD simulations MC simulations
1iep 3.29 3.83
2f4j 3.01 2.63
Table 7.1: RMSDs of the activation loop between the initial and ﬁnal struc-
ture of the simulations. RMSD are in ˚ A and calculated after the superimpo-
sition of the two conﬁgurations.
Table 7.1 shows that both techniques give similar RMSD. However, sev-
eral points have to be clariﬁed. The number of sweeps performed using MC
simulations is twenty times smaller that what it should be. The starting struc-
tures are diﬀerent. Whereas the MD starting structures have been minimisedCHAPTER 7. BIOLOGICAL SYSTEMS 117
without a ligand, the structures used in the MC simulations were minimised
with the ligand inside. Thus, the starting conformation for the MC simula-
tions is biased toward the bound state. So the use of MC simulations using
CRA manage to sample the activation loop of the kinases with the same
eﬃciency as MD, but manage it faster and in this particular case, are less
sensitive to the starting structure, as the penalty introduced by the diﬀer-
ence in conformation is easily overcome during the MC simulations (however
MD simulations have to deal with the explicit representation of the solvent
whereas MC simulations were performed using GBSA).
To try to get more information about the conformational changes, the
g cluster tool from the gromacs package has been used for both methods on
both systems141,142. For the MC simulations, conformations were saved every
10 000 steps and used as a trajectory. For the MD simulations, conformations
were saved every 10000 steps (20 ps) and used as a trajectory. Owing to the
diﬀerence in the length of the simulations for both methods, the number of
snapshots in the MD trajectories is twice the number of snapshots in the
MC trajectories. Diﬀerent values of the cut-oﬀ and two diﬀerent methods to
compute the distance distance values for the RMS matrix have been used.
The single linkage method has been use to build the clusters. The number of
clusters identiﬁed are given table 7.2 for the MC simulations and table 7.3
for the MD simulations.
For each simulations, the RMS matrix has been computed using two
diﬀerent methods. The ﬁrst one, by computing the RMSD of the distances
(column indexed RMSD in table 7.2) and the second one, by computing
the RMS deviation after ﬁtting (column indexed RMS in table 7.3) when
building the RMS matrix. For each of the two methods, the clusters have
been calculated using both the backbone and all the atoms of the activation
loop.
Table 7.2 and 7.3 show that there are very few clusters for the diﬀerent
conformations of the activation loop for all but small values of the cut-oﬀ
when only the atoms of the backbones are used. Furthermore, the number
of clusters obtained from the MC simulations is greater than the number
obtained from the MD simulation. This trend is inverted for the number ofCHAPTER 7. BIOLOGICAL SYSTEMS 118
2f4j 1iep
Backbone All atoms Backbone All atoms
RMS RMSD RMS RMSD RMS RMSD RMS RMSD
1 1 1 1 1 1 1 2 1
0.7 1 1 6 1 13 1 18 1
0.6 10 1 125 3 145 7 167 5
0.5 191 5 414 91 406 56 438 72
Table 7.2: Number of clusters for the activation loop of the 1iep and 2f4j MC
simulations. The values of the cut-oﬀ are represented in the ﬁrst column.
2f4j 1iep
Backbone All atoms Backbone All atoms
RMS RMSD RMS RMSD RMS RMSD RMS RMSD
1 1 1 9 3 1 1 1 1
0.7 7 1 704 717 1 1 194 143
0.6 63 2 982 992 4 1 727 745
0.5 298 38 1001 1001 74 1 953 999
Table 7.3: Number of clusters for the activation loop of the 1iep and 2f4j MD
simulations. The values of the cut-oﬀ are represented in the ﬁrst column.CHAPTER 7. BIOLOGICAL SYSTEMS 119
clusters obtain when all the atoms of the activation loop are used, prob-
ably due to the method used to sample side-chains. However, for the MC
trajectories, the number of cluster for a given calculation is greater for the
1iep simulation, meaning there are more conformational changes during the
simulation conﬁrming the results from table 7.1. Another interesting point,
is that due to the use of rigid backbone unit moves outside the activation
loop, the brownian motion of the protein (drift) is less important for the MC
simulations and such behaviour could explain the number of clusters for the
2f4j kinanse.
Figure 7.4 shows the main clusters for both MC simulations (clusters in
blue in table 7.2) For the simulations starting from the 2f4j and 1iep struc-
tures without ligands, 3 of the 6, and 6 of the 18 clusters are represented
respectively (the most representative clusters during the trajectories). The
clusters and the step number of the trajectories are related. Clusters ap-
pear sequentially along the trajectory and do not return, characterising a
displacement of the activation loop. This shows again the important changes
of conformation undergone by the activation loop during the simulations due
to the use of the CRA moves, where the level of sampling can be compared
to the MD method.
The CRA algorithm managed to enhance the sampling of the activation
loop, however the complete interconversion of the loop is quite demanding in
terms of CPU time. An interesting challenge would be to convert the DFG
loop between two structures bound to diﬀerent substrates by mutating one
ligand into another.
Free energy perturbation
Figure 7.1(b) shows that the superimposed structures of the 2f4j and 1m52
proteins share the same conformation of the activation loop but a diﬀerent
DFG loop conformation.
However the primary structures are diﬀerent. The 2f4j crystal structure
presents the H396P mutation. The modeller tool143 has been used to mutate
the residue 396 of the 1m52 crystal structure into a proline. To observe a
change in the conformation of the DFG loop, both VX6 (for 2f4j) and P17CHAPTER 7. BIOLOGICAL SYSTEMS 120
(a) Clusters for the 2F4J simulation.
(b) Clusters for the 1IEP simulation.
Figure 7.4: Superimposition of the clusters for the simulations with both 2f4j
and 1iep crystal structure without ligands. Clusters have been computed
using all the atoms of the activation loop, a 0.7 ˚ A cutoﬀ, the RMS deviation
on the ﬁtted structure and the single linkage method. Initial structures are
represented in green.CHAPTER 7. BIOLOGICAL SYSTEMS 121
Figure 7.5: VX-6 (right hand side) and P-17 (left hand side).
(for 1m52) ligands have been perturbed one into each other. Figure 7.5 shows
the geometry of both ligands.
The two crystal structure have been minimised prior to the RETI sim-
ulations. For both crystal structure the same protocol has been used. Five
hundred cycles of minimisation in GBSA using the amber forceﬁeld have
been performed. Then a scoop of 15˚ A around the VX6 compound with a
inner sphere of 10˚ A as been created, residues in the outer sphere have been
altered so the the total charge of the system was lowered to zero. For each
scoop an equilibration of 50000 MC steps at 0 K and 298 K in GBSA using
dual topology with both ligands present and a λ of 0.5 have been run to
remove the most important steric clashes. For each of the two crystal struc-
tures, two set of simulations have been run, each of three RETI simulation
starting with a diﬀerent random seed using. For the ﬁrst set, the CRA move
as described in the literature83 has been used on ﬁve residues. The DFG
loop and the ﬁrst neighbouring residues on both sides. For the second set of
simulations, the CRA with the extended prerotation move as described in
section 5 has been used on the same ﬁve residues. Each set was composed
of 50 RETI moves of 30000 steps using the dual topology method and the
values of λ were scattered between zero and one identically to the values used
for the lysozyme simulations (see section 6.2.3).
None of the twelve simulations managed to give an accurate value of theCHAPTER 7. BIOLOGICAL SYSTEMS 122
relative binding free energy. The ∆∆Gbind is several hundreds of kcal/mol
negative going from P17 to VX6 in the 1m52 protein (ranging from -570
kcal/mol to -415 kcal/mol). For the perturbation VX6 to P17, the relative
binding free energy is two orders of magnitudes higher (but with a positive
value). These results however are not very surprising. Figure 7.6 shows the
last structure of three RETI simulations at λ = 1 for both perturbations
(VX6 to P17 in 2f4 and P17 to VX6 in 1m52) and the RMSD for respective
simulations are plotted ﬁgure 7.7.
Figure 7.6: Superimposition of the last structures at λ = 1 for 3 RETI sim-
ulations starting from the 2f4j (left) and 1m52 (right) crystal structures. All
the atoms of the DFG loop and the ligand for λ = 1 are represented. The
initial conformation of the ligands are represented in black.
Figure 7.6 stresses several points. The sampling of the backbone of the
DFG loop does not allow the interconversion of the conformation of the loop.
This is true for simulations starting from both crystal structures. The ligands
at λ = 1, do not undergo major changes of conformation. The two issues can
be linked together to explain the results of the relative binding free energies.
The DFG loop cannot sample suﬃcient phase space, hence the existence of
de-favourables interaction with the ligands. Such interactions seem to have
more eﬀect mutating the VX6 into P17 in the 2f4j crystal structure than
mutating P17 into VX6 in the 1m52 crystal structure. This is simply due to
the initial conformations of both ligands and proteins and the steric clashes
resulting from such conformations.CHAPTER 7. BIOLOGICAL SYSTEMS 123
Owing to the size of the ligand and the conformation of the DFG loop,
sampling for the RETI simulations starting from the 1m52 crystal structure is
more important than the sampling achieved in the RETI simulations starting
from the 2f4j crystal structure.
(a) (b)
(c) (d)
Figure 7.7: RMSDs of the DFG loop for the RETI simulations starting from
the 2f4j(left) and 1m52 (right) crystal structures at λ = 1. Top row represents
the RMSDs with all the atoms and the bottom row represents the RMSDs
for the atoms of the backbone only.
Figure 7.7 shows good sampling of the DFG loop. However, the sampling
of the DFG loop is not suﬃcient to achieve the necessary interconversion.
The RMSD between the two crystal structures for the DFG loop is 5.52 ˚ A
for all the atoms and 2.99 ˚ A for the backbone atoms only.CHAPTER 7. BIOLOGICAL SYSTEMS 124
Figure 7.7(b) shows that the RMSD for one of the RETI simulations is
quite diﬀerent from the others (green curve ﬁgure 7.7(b)). This is mainly
due to changes in the conformation of the side chain. Figure 7.7(d) shows
the RMSD for the atoms of the backbone only and the RMSD (green curve)
is not that dissimilar to the other simulation being however diﬀerent. The
green conformation in ﬁgure 7.6(b) shows that the side chain of the pheny-
lalanine in green (simulation corresponding to the RMSD plotted in green
ﬁgure 7.7(b) and ﬁgure 7.7(d)) adopts a diﬀerent conformation than for the
others simulations, explaining the increase in the RMSD.
The use of the CRA algorithm has shown signiﬁcant increase in the sam-
pling of the activation loop of the Bcr-Abl kinases. Nevertheless, the increase
of sampling is not suﬃcient to sample the complete opening of the loop or
the interconversion of the DFG loop during free energy calculations. How-
ever, such changes in conformations can not be observed using MD methods
either. The size of the change and the resources available seem to draw a
limit to the use of the CRA algorithm.
Next we have have applied the CRA algorithm to the PDE5 class of
phosphodiesterase to try to compute accurate relative binding free energy
between the commercial drugs viagra and cyalis.
7.2 PDE5
Phosphodiesterases are a large class of enzymes mediating a number of phys-
iological processes ranging from immune response to platelet aggregation to
cardiac and smooth muscle relaxation. In particular, phosphodiesterase 5
(PDE5) plays an important role in mediating sexual arousal, and it is the
central molecular target in treatments of erectile dysfunction.
7.2.1 Protein function and structure
Phosphodiesterases usually hydrolyse the second messengers cyclic guano-
sine monophosphate (cGMP)and cyclic adenosine monophosphate (cAMP)
which are key components in the transduction cascades. By reducing the cel-CHAPTER 7. BIOLOGICAL SYSTEMS 125
lular level of cGMP and cAMP, phosphodiesterases regulate the mechanisms
described above144.
There are 11 classes of phosphodiesterases; the class 5 (PDE5) is involved
in mediating sexual response. Several drugs are known to bind to PDE5, most
famous being sildenaﬁl (viagra) and vardenaﬁl (cyalis) (both represented in
ﬁgure 7.8).
Figure 7.8: Sildenaﬁl (top) and vardenaﬁl (bottom).
These drugs have been designed so that the cross-reactivity with other
families of phosphodiesterases is very low so they mostly target the PDE5
proteins145–147 and both drugs have similar structures and the conformation
of the bound state of the protein with both drugs is very similar.
However the vardenaﬁl binds the PDE5 protein about 30 times tighterCHAPTER 7. BIOLOGICAL SYSTEMS 126
Figure 7.9: Structures involved in the binding mechanisms of the sildenaﬁl
(grey). Glutamide switch (green), hydrophobic clamp (blue) and loop clamp
(red).
than the vardenaﬁl to the PDE5 protein catalytic domain. Two binding inter-
actions have been reported in the literature; the glutamide switch148 and the
hydrophobic clamp149. Furthermore to the existing binding modes, Zagrovic
et al. quotes a binding mechanisms in which both the H and M loops of the
protein execute sizable conformational changes150 called the ”loop clamp”.
Figure 7.9 shows a representation of the various binding modes for the silde-
naﬁl in the PDE5 protein.
The PDE5 protein have been previously studied using MD methods150.
Zagrovic et al. has performed several simulations on this system. Simulations
where run on the 1udt crystal structure. The missing part of the H-loop where
added using the modeller package143 and ten MD simulations of 3 ns each
using diﬀerent starting velocities from the Maxwell-Boltzmann distribution
at 300 K were run. Simulations were run using the GROMOS 45A3 force-CHAPTER 7. BIOLOGICAL SYSTEMS 127
ﬁeld151 and the GROMOS package141. Protein was solvated using a truncated
octahedron box ﬁlled with SCP152 water molecules. Thermodynamical inte-
gration was performed using 26 values of λ equidistant between 0 and 1. For
each λ 500 ps of simulation was carried out, the ﬁst 100 ps used to equilibrate
the system. Summary of the results of this work can be found section 7.2.3
The crystal structures of the PDE5 catalytic domain bound to both silde-
naﬁl153 and vardenaﬁl154 are available in the PDB database under the refer-
ences 2h42 and 1uho respectively.
Insight of the binding pocket of the protein illustrates the complexity
of the system. The binding pocket contains the ligand, two divalent cations
(Mg2+ and Zn2+) and some crystallographic water molecules involved in ion
coordination (see ﬁgure 7.10).
Figure 7.10: Binding pocket of the 2h42 crystal structure. The ligand is rep-
resented in grey, the oxygen of the water molecules in red, the zinc in grey
and the magnesium in green. Also represented, the residues involved in the
metal coordination.
The ions are bound to waters and several side-chains of the protein154. The
zinc is coordinated to the side chains of His 617, Asp 654, Asp 764, His 653
and two water molecules. The magnesium is bound to ﬁve water molecules
and the side chain of Asp 654. Three of the water molecules bridging theCHAPTER 7. BIOLOGICAL SYSTEMS 128
metal to the His 657, Asp 682 and His 685.
Such complexity raises several issues to assess during the equilibration of
the system.
The next section will describe the parametrisation of the system in Pro-
toMS51 to integrate all the variables relevant to the bodies present in the
binding pocket.
7.2.2 Parametrisation
To study the PDE5 protein two crystal structures have been used, 1tbf and
2h42, both structure have been prepared in the same way. All the MC simu-
lations have been run using GBSA solvation. However, GBSA in ProtoMS51
is not parametrised to deal with cations such as magnesium or zinc. So the
force ﬁeld has to be parametrised as one cannot simply ignore the presence
of the ions.
To make sure the correct parameters are chosen, literature was gathered
to select the parameters to use with both ions155–160. Determining the Born
radius for the zinc is not straight forward. The Born radius changes with the
coordination state of the zinc. The value of the free energy of solvation for a
single ion in a solvent continuum is given by:
∆GBorn = −
q2
8πr
(
1
ǫ0
−
1
ǫ
) (7.1)
where q is the charge of the ion, r the Born radius and ǫ0 and ǫ the vacuum
and continuum permittivity.
The value of the Born radius as well as some scaling parameters are used
by ProtoMS51 to compute the energy of solvation for an ion. The Born radius
values for both the zinc and the magnesium have been chosen from Babu et
al.155 (see table 7.4).
The values in the gborn.parameter ﬁle are not the values of the Born
radii, but the values used by ProtoMS51 with a scaling factor to compute
the correct Born radii and hydration energies. To use the correct value in the
simulation, code has been modiﬁed so the value of the Born radius and theCHAPTER 7. BIOLOGICAL SYSTEMS 129
M2+ −∆Ghyd(kcal/mol) RBORN(˚ A)
Zn2+ −467exp −477b 1.40a 1.4b
Mg2+ −437exp −433b 1.50a 1.5b
Table 7.4: Absolute hydration free energy and Born radii for the zinc and
magnesium cations; from the literature (a) and used in ProtoMS51 (b).
absolute hydration energy were printed in the output ﬁles. Then trial and er-
ror for values of the parameters has been applied until the single point energy
of one ion in the Born continuum was close enough to the experimental value
(typically a value of the energy within 10 kcal/mol from the experimental
value69). The Born radius used in ProtoMS51 and the respective hydration
energy for both ions can be found table 7.4.
7.2.3 Simulations
Once the parameters for both zinc and magnesium have been set to the
correct value, the question of the crystallographic water remained. Some
of the water molecules play an important part in the coordination of the
cations154. These waters cannot be removed from the binding pocket, so a
script has been written to build water shells using the position of the oxygens
from the crystal structure. The water shell containing all the oxygens within
a 5 ˚ A radius centred around the ions and the ligand (sildenaﬁl) has been
built.
Then the oxygens were transformed into TIP3P61 water molecules using
the xleap tool from the amber109 package. For a water molecule to be used
in ProtoMS51, its geometry has to be exactly a TIP3P or TIP4P one; no
variation in the bond length or bond angle of the water are expected. One
drawback of using xleap is that this module does not favour any hydrogen
bonding. All the TIP3P molecules are orientated in the same way. However
a short minimisation of the structure would correct this problem. At this
point, the sander module cannot be used to minimise the structure as this
would change the geometry of the water molecules. ProtoMS51 has been usedCHAPTER 7. BIOLOGICAL SYSTEMS 130
to minimise the system. A careful minimisation of the system (2h42 protein)
was performed as follow:
• First 15 blocks of 10000 MC steps at 0 K have been performed sampling
the whole system.
• Then 5 blocks of 10000 MC steps at 298 K have been performed sam-
pling only the water molecules.
• And ﬁnally 5 blocks of 10000 MC at 298 K have been performed sam-
pling the whole system.
The ﬁgure 7.11 show the total energy during the minimisation process.
Figure 7.11: Energy in kcal/mol of the system during the minimisation pro-
cess for the 1tbf protein.
Then a scoop of the protein has been created. The scoop consist of two
spheres (inner and outer) of respective radius 12 and 17 ˚ A from the sildenaﬁl
and the two ions. Residues 93, 84, 201, 203 and 204 were removed from the
scoop, and the lysine 85 was deprotonated, so the total charge of the protein
was brought to zero.
Then three dummy atoms were added to one hydrogen of methyl group of
the sildenaﬁl for the mutation sildenaﬁl to vardenaﬁl. The bonds between the
dummies and the hydrogen were set to 0.2 ˚ A. Then the system was minimised
to make sure the added dummies were not a source of any steric clashes. ThreeCHAPTER 7. BIOLOGICAL SYSTEMS 131
short MC simulations of ten thousand steps at 0 K each were run. First, a
simulation with only the protein allowed to move, second a simulation with
the protein and the ligand allowed to move and the third simulation with
the whole system allowed to move. The ﬁnal energy of the system was -6806
kcal/mol. To ﬁnish the equilibration process, 10000 equilibration steps were
performed.
The coordinates of the protein, the ions, the ligand and the water molecules
were saved and used as initial structure for the simulations. Several simula-
tions where run.
All the simulations were performed using constant temperature and num-
ber of molecules, using GBSA solvation and the CRA algorithm between the
scoop residues 39 and 70 (H-loop). Both the ions and the crystallographic
water molecules involved in the binding were conserved. The water shell was
centre around a 14 ˚ A spheres, and a of 0.1 kcal/mol.˚ A2 was applied at the
boundaries. For the 2h42, protein simulations for both the bound the un-
liganded (unbound) structures were performed each composed of two million
MC steps. Acceptance rates for both simulations are plotted in table 7.5
System Zn Mg Protein CRA
Bound 11.3 % 8.9 % 28.8 % 27.8 %
Unbound 21.1 % 16.2 % 28.4 % 27.8 %
Table 7.5: Acceptance rates of zinc (Zn) and magnesium (Mg) ions and the
protein during the two simulations (bound and unbound).
Acceptance rates for both simulations are very similar. The ions seem to
achieve better sampling in the unbound protein rather than in the bound
protein. Figure 7.12 shows the binding pocket at diﬀerent stages of the sim-
ulation (initial in dark blue, ﬁnal in red and intermediate in cyan).
Figure 7.12 shows several points. Both ions retain their coordination
states (not represented in ﬁgure 7.12 are the side chains involved in the co-
ordination). The position of the zinc remains very close to its initial position
while the magnesium moves further away from the initial position. The be-
haviour of the ions is in good agreement with the literature150. The evolutionCHAPTER 7. BIOLOGICAL SYSTEMS 132
Figure 7.12: Binding pocket at diﬀerent stages of the simulation for the bound
protein. Sildenaﬁl(sticks), water molecules (sticks) and zinc (small sphere)
and magnesium (big sphere) ions are represented at the diﬀerent stages. The
initial structure of the protein is also represented.
of some intermolecular features have been plotted ﬁgure 7.13, and compared
to the values from the literature150.
The distance between the two ion and the distance between the sildenaﬁl
and the valine 157 plotted in ﬁgure 7.13(b) and 7.13(c) are close to the
results by Zagrovic et al. for both the simulations with the bound and the
holo structures. However, the RMSD is about one order of magnitude smaller.
This can be explained by several facts. First, the CRA have only be used on
the H-loop, the other residues have been sampled using standard ProtoMS51
moves. Second, it is likely that the minimisation process undergone by the
protein has biased the conformation of the protein toward a low energy state,
where the ligand is tightly bound to the protein. And third, in the work from
Zagrovic et al., part of the H-loop was not present in the crystal structure
and modelled using the modeller package143. The modelled H-loop undergoesCHAPTER 7. BIOLOGICAL SYSTEMS 133
(a) (b)
(c) (d)
Figure 7.13: Inter-ions(b) and H670 to N789(a) distances. RMSD during the
simulation(c) and distance between the Cα of the valine 157 and the C24 of
the sildenaﬁl (in blue in ﬁgure 7.8) (d). RMSD are calculated on the backbone
atoms only. Values for the simulation without sildenaﬁl are plotted in red.
Values for the simulation with the sildenaﬁl are plotted in black. all distances
are in ˚ A
large scale motion (up to 9 ˚ A) and such motions can bias the value of the
RMSD. Figure 7.13(a) shows the distance between the histidine 670 and
the glutamine 789. The distance between the two residues during the bound
state simulation is consistent with the value from the literature150 (22 ± 6
˚ A). The distance for the holo simulation is diﬀerent from the value of the
literature150 (29 ± 4 ˚ A). However, ﬁgure 7.13(a) clearly shows that both
curves are drifting away from the initial value and the MD simulations wereCHAPTER 7. BIOLOGICAL SYSTEMS 134
run for a relatively long time (3 ns). The distance between the two residues
for the bound protein is getting lower, whereas the distance for the unbound
protein is getting bigger. This behaviour is again in accordance this the work
of Zagrovic et al..
So MC simulations using the CRA algorithm were able to reproduce with
accuracy the results of the MD simulations. Such simulations were used to
try to reproduce the experimental and theoretical value of the relative bind-
ing free energy between the sildenaﬁl and vardenaﬁl. Results of the RETI
simulations are summarised table 7.6.
experimenta experimentb MD150 MC/CRA
∆∆G◦
bind -2.2 to -1.1 -1.4 to -1.3 -0.6 0.2±0.9
Table 7.6: Experimental and theoretical relative binding free energies between
vardenaﬁl and sildenaﬁl in kcal/mol. Calculated from IC50 values a and from
KD values b
RETI simulations were run using the dual topology method in the GBSA
continuum at constant temperature on the scoop of the 2h42 PDE5. CRA
moves were performed between the scoop residues 39 to 70 (H-loop). The
values of λ are similar to the values used in the lysozyme and kinase simula-
tions. For each λ, 50 RETI moves of 30000 MC steps was run mutating the
sildenaﬁl into vardenaﬁl. Owing the high similarity between the two ligands
no equilibration at λ = 0.5 was run.
Results in table 7.6 shows that both MD and MC simulations overestimate
the binding aﬃnity of the sildenaﬁl. However, the MC simulations using
the CRA algorithm on the H-loop overestimate the binding energy of the
sildenaﬁl from around 1 kcal/mol, but this value is within the margin of
the standard error. So the computed relative binding free energy using MC
method is very close to the computed relative biding free energy using MD
method.CHAPTER 7. BIOLOGICAL SYSTEMS 135
7.3 Concluding remarks
Biological targets such as Bcr-Abl kinases and PDE5 phosphodiesterase have
been investigated using MC simulations and the CRA algorithm. Trying to
reproduce the experimental observations on the kinase conformations is still
beyond the capabilities of the CRA. However, although the use of MC simu-
lation and CRA algorithms did not managed to inter-convert the DFG loop
of the kinase or fully open the activation loop after removing the ligands,
the MC simulations using the CRA algorithm of comparable quantity to the
MD simulations previously run in-situ.
In the case of the PDE5 protein, the use of of the CRA algorithm leads to
the same level of sampling as MD simulations, both from a conformational
and an energetic point of view. The relative binding free energy between
the vardenaﬁl and the sildenaﬁl computed using MC with the CRA algo-
rithm leads to the same results as the computed relative binding free energy
obtained with MD method.
The CRA has proved once again to be a useful tool to sample proteins
using statistical mechanics. The next chapter will conclude the work done
and open new perspectives on the use of the CRA algorithm.Chapter 8
Concluding remarks and
perspectives
8.1 Concluding remarks
This research set out with the aim of implementing a novel method to sam-
ple large backbone moves for proteins, that provides enhanced sampling of
protein loops and is still fast enough to be used in pharmaceutical drug de-
sign. Several algorithms have been reviewed in chapter 4 and the choice has
been made to implement the CRA algorithm. To satisfy this aim, chapter 5
describes the implementation and testing of the CRA algorithm in the Pro-
toMS51 package.
The CRA has been implemented as a new move in ProtoMS51. Two types
of moves for the CRA are available, one as described in the literature83 and
one where the length of the prerotation move can be chosen to ﬁt the require-
ment of the user. The user also has the possibility to choose between diﬀerent
parameters by changing the value of few simple key words in the input ﬁles.
The CRA has provided signiﬁcant enhancement of the sampling of the back-
bone of the protein. The speed of the CRA moves has been tested against
the speed of rigid-unit backbone moves and the penalty in speed (one CRA
move is about twice as slow as a rigid unit backbone move in ProtoMS51) isCHAPTER 8. CONCLUDING REMARKS AND
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regarded to be negligible with respect to the increase of acceptance rate and
sampling provided by the CRA algorithm.
The increase in the sampling enables ProtoMS51 to achieve the same level
of sampling as classical MD simulations. Once the CRA was successfully
implemented and thoroughly tested, it was used to try to solve biological
problems that involve large changes in the backbone conformation of the
protein.
The CRA algorithm has been applied to the several biological targets to
try to reproduce or better MD results. Systems have been chosen of biological
interest, the lysozyme protein, the Bcr-Abl kinase and the PDE5 phospho-
diesterase. For the three systems, MC simulations with CRA moves have
been use to sample conformational loop problems, respectively the change in
conformation of the F-loop, the switch in the DFG/activation loop and the
change of conﬁguration of the H-loop.
The use of the CRA algorithm has enhanced the sampling for the three
systems. The trajectory of the simulations shows that the use of the CRA
allows the loops to sample diﬀerent conformations. Other technique such as
parallel tempering have been used to enhance the sampling of side chains
and have led to very good results in terms of sampling.
RETI simulations have been computed using the CRA moves to try to
compute precise relative binding free energies. Although the use of the CRA
has increased the sampling, in most cases, the computed relative binding free
energies could not reproduce the experimental results.
It is not clear if this issue is only related to the sampling of the backbone,
or of the sides chains, the size of the ligand/binding pocket and the accuracy
of the forceﬁeld. However the CRA algorithm could be improved in a few
ways.
8.2 Future work and perspectives
The capabilities of the CRA algorithm have been barely scratched during
this research and a lot more can be done. The combined use of the CRA
algorithm, the deﬁnition of moves through ProtoMS51 and the use of methodsCHAPTER 8. CONCLUDING REMARKS AND
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such as RETI and PT may lead to great discoveries in the ﬁeld of molecular
modelling.
The two parameters controlling the force of the bias and the acceptance
rate in the CRA moves are those used in the literature. A ﬁrst implementa-
tion could be to let the user choose and optimise which parameters to use
(but the optimisation is likely to be case dependent). However changing the
parameters would require extreme caution as the wrong parameters would
lead to poor sampling or poor acceptance rate.
The parallel tempering method has proved to give good results in the case
of the valine 111 of the lysozyme, allowing the sampling of both position of
the angle of the rotamer χ. It would be interesting to sample a protein using
diﬀerent probabilities of move types for each temperatures. At higher tem-
peratures, the loop involved in large scale (or slow motion) conformational
change would be sampled with the highest probability (for example ten CRA
move every eleven ProtoMS51 moves at 500 K) whereas at standard tem-
perature (298 K), the ratio CRA moves per total moves would be lowered
(one CRA move every four moves). Such an approach would not brake de-
tailed balance and would provide greater sampling of the protein loop. This
approach would be very similar to the TEE-REX algorithm161,162 from Ku-
bitziki et al. where at higher temperature only the slow degrees of freedom
are sampled.
It could be useful to implement more features into the CRA algorithm. If
a protein undergoes a large change of conformation in more than one loop,
the only way to sample all the loops so far is to allow CRA moves on all the
residues located within the loop boundaries. This would lead to sampling
problems if a scoop of the protein was to be used were some residues are
missing or have to be kept ﬁxed.
One possible solution would be to have the option to use the CRA move
on more than one loop. Using an array to store the number of loops, and the
residue number of both ends of each loops, the code would pick up one loop
randomly and perform a CRA move within this particular loop boundary.
Given the good results provided by parallel tempering, it would be of
great interest to be able to run both PT and RETI simulations in the sameCHAPTER 8. CONCLUDING REMARKS AND
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simulations (so each λ value could exchange conﬁgurations with the PT sim-
ulations). A method to couple protein change with λ to capture large scale
rearrangemnets as we mutate the ligand may lead to better accuracy in the
computed relative binding free energy. However such a method would be
extremely costly.
With a little work to add a few extra options, the CRA could became an
even more powerful tool to use to sample large backbone moves using MC
simulations.List of Figures
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